Undergraduate CHEM401L ⭐ 2 Credits Semester 6

Biochemistry I Laboratory

Laboratory companion to Biochemistry I. Introduces students to core biochemistry laboratory techniques: protein purification, SDS-PAGE, Western blotting, spectrophotometric enzyme assays, ELISA, and column chromatography. Students execute a semester-long protein purification and characterization project.

📅 Studied by Skipper on 2026-10-01

📖 Core Concepts

Claude Opus 5.5

Core Concepts: Biochemistry I Laboratory

1. What This Subject Is Really About

Skipper, here is the central problem of the biochemistry laboratory. Proteins are a few nanometers across. You cannot see them, weigh them individually, or pick them up. A crude cell lysate contains thousands of different proteins, and the one you care about may be under 1% of the total. Everything in this course is a solution to two linked problems:

  1. Separation: How do I isolate one molecular species from thousands of chemically similar ones?
  2. Transduction: How do I convert an invisible molecular property (amount, size, identity, activity, fold) into a number I can read on an instrument?

Every technique you will use answers one or both questions. Ammonium sulfate precipitation, IMAC, ion exchange, and size-exclusion chromatography exploit differences in solubility, coordination chemistry, charge, and hydrodynamic size. Bradford, BCA, A280, Western blots, ELISA, kinetics, and CD convert those molecules into absorbance, light emission, or differential absorption of polarized light.

A useful mental model is that a protein purification works like an interrogation. Each chromatography step asks the mixture one question ("Do you bind nickel?", "Are you negatively charged at pH 8?", "Are you bigger than 5 nm?"). Your target is the molecule that answers every question the way you predicted. No single question isolates it. A well-designed sequence of orthogonal questions does.

Robert Scopes frames purification as a sequence of steps, each exploiting a different physical property, with the aim of maximizing purity while minimizing loss and time [Scopes, 1994]. The Elliotts' manual takes a similar practical approach: each protocol is a controlled experiment whose output must be quantified and judged against appropriate controls [Elliott & Elliott, 2009].

Much of this course draws on what you already know:

  • CHEM302 (Analytical): calibration curves, linear dynamic range, limits of detection, and interferences appear in every protein assay.
  • CHEM301 (Thermodynamics): salting out, dialysis equilibria, and binding constants are chemical-potential arguments.
  • CHEM303 (Quantum/Spectroscopy): Beer–Lambert, chromophores, and the electronic transitions of the peptide bond underlie A280 and CD.
  • MATH201 and MATH301: nonlinear regression for Km, error propagation, and least-squares deconvolution of CD spectra.
  • CHEM401 and BIOL201: the structure–function concepts and recombinant expression systems you now manipulate at the bench.

2. Protein Quantification: Every Assay Measures Something Other Than "Protein"

The first counterintuitive idea in this course is that no assay measures "protein concentration" directly. Each measures a specific chemical feature (aromatic side chains, dye-binding residues, copper-reducing groups) and converts it to "protein" by comparison with a standard. This is why the same sample can give different answers in different assays, and why that discrepancy is information, not failure.

2a. Absorbance at 280 nm (Beer–Lambert)

Proteins absorb near 280 nm mainly because of the indole ring of Trp and the phenol ring of Tyr, with a small contribution from disulfide bonds (cystine). These are π→π* transitions of the kind you studied in CHEM303. The Beer–Lambert law applies:

A = ε · c · l

  A  = absorbance (dimensionless)
  ε  = molar extinction coefficient (M⁻¹ cm⁻¹)
  c  = molar concentration (M)
  l  = path length (cm, usually 1)

For a folded protein in water, ε280 can be predicted from sequence [Pace et al., 1995]:

ε₂₈₀ (M⁻¹ cm⁻¹) ≈ 5500·n(Trp) + 1490·n(Tyr) + 125·n(cystine)

Example: a protein with 2 Trp, 8 Tyr, 1 disulfide
  ε₂₈₀ = 11000 + 11920 + 125 = 23 045 M⁻¹ cm⁻¹

Strengths: the method is non-destructive, fast, and needs no standard if ε is known. Weaknesses:

  • Nucleic acids absorb strongly at 260 nm, with a substantial tail at 280 nm. An A260/A280 ratio well above ~0.6 signals nucleic acid contamination in a protein prep.
  • Light scattering from aggregates inflates apparent absorbance. Check the baseline at 320–340 nm, where proteins should not absorb.
  • A protein with no Trp or Tyr is essentially invisible at 280 nm.

2b. The Bradford Assay

Coomassie Brilliant Blue G-250 exists in acidic solution in protonation states with different colors: a cationic red form (λmax ≈ 470 nm), a neutral green form (≈ 650 nm), and an anionic blue form (≈ 595 nm). When the dye binds protein, mainly through electrostatic interactions with Arg (and to a lesser extent Lys and His) plus hydrophobic and aromatic contacts, the blue anionic form is stabilized. You read A595 [Bradford, 1976].

  • Why it varies between proteins: the response depends on Arg and aromatic content. An Arg-rich protein reads "high" against a BSA standard.
  • Why the curve bends: free dye also absorbs at 595 nm, and the dye can be depleted. The standard curve is inherently nonlinear over wide ranges, so fit a curve or restrict yourself to the linear region.
  • Interferences: detergents, especially SDS, interfere strongly. Strongly basic buffers can also interfere.

2c. The BCA (Bicinchoninic Acid) Assay

This is a two-stage redox chemistry [Smith et al., 1985]:

Step 1 (biuret reaction, alkaline):
    protein (peptide bonds; Cys, Tyr, Trp side chains) + Cu²⁺  →  Cu⁺

Step 2 (chelation):
    Cu⁺ + 2 BCA  →  [Cu(BCA)₂]⁺     purple complex, λmax = 562 nm

Because peptide bonds contribute, BCA is less sequence-dependent than Bradford. It tolerates many detergents. Its weakness is its chemistry: anything that reduces Cu²⁺ (DTT, β-mercaptoethanol, ascorbate) or chelates copper (EDTA) will corrupt the measurement. Raising the incubation temperature increases the peptide-bond contribution and sensitivity.

Choosing an assay is like choosing a witness. The A280 witness only sees aromatic rings. The Bradford witness mostly notices arginines. The BCA witness counts anything that can reduce copper. Pick the witness that your sample's buffer can't bribe.

2d. Standard curves and the meaning of "mg/mL"

Bradford and BCA are relative methods. When you report "2.1 mg/mL by Bradford," you really mean "this sample produced the same dye response as 2.1 mg/mL BSA." BSA is a historical convention, not a universal truth. Bovine γ-globulin gives a noticeably different Bradford curve. For a pure protein with known sequence, A280 with a computed ε is often the most accurate method, despite looking the least sophisticated.


3. Purification Strategy: Bookkeeping, Salting Out, Spinning, and Diffusion

3a. The purification table: the accounting of a prep

Every step of a purification is judged by two competing quantities, purity and yield. You track them with a purification table [Scopes, 1994]:

Total activity (U)         = activity concentration (U/mL) × volume (mL)
Total protein (mg)         = protein concentration (mg/mL) × volume (mL)
Specific activity (U/mg)   = total activity / total protein
Fold purification          = specific activity(step) / specific activity(crude)
Yield (%)                  = total activity(step) / total activity(crude) × 100

Specific activity is your purity meter. Yield is your loss meter. If you do five steps at 70% yield each, you keep only 0.75 ≈ 17% of your protein. This compounding loss is why Scopes stresses using as few steps as possible and ordering them intelligently. A typical order is a high-capacity, crude step first (precipitation or capture), then higher-resolution steps (ion exchange, SEC) later.

One surprise: yield can exceed 100%. This happens when an inhibitor present in the crude extract is removed, so measured activity rises. Such a result tells you something about the biology, not just the bookkeeping.

3b. Ammonium sulfate precipitation (salting out)

At low ionic strength, adding salt increases protein solubility ("salting in"), because ions screen attractive electrostatic interactions between protein molecules. At high ionic strength, salt decreases solubility ("salting out"). Here is the thermodynamic picture, which connects to CHEM301:

  • Highly hydrated ions like SO42− tie up water molecules and increase the surface tension of water.
  • This raises the free-energy cost of keeping hydrophobic surface patches of the protein exposed to solvent.
  • Protein–protein association, which buries those patches, becomes favorable, and the protein precipitates.

At high salt, solubility is described empirically by the Cohn equation:

log S = β − Kₛ · I

  S  = protein solubility
  β  = intercept (depends on protein, pH, temperature)
  Kₛ = salting-out constant (depends on protein and salt)
  I  = ionic strength

Ammonium sulfate is the salt of choice for practical reasons. It is extremely soluble (~4 M at saturation near room temperature). It sits high in the Hofmeister series as a stabilizer, so it tends to preserve native structure. It is cheap, and precipitated proteins usually redissolve in native form. Fractions are described as "% saturation." A typical protocol takes the supernatant from a 0–40% cut and then collects the pellet from a 40–60% cut.

Practical point: ammonium sulfate is slightly acidic in solution and releases NH3 at high pH, so buffer your solution. Add solid salt slowly with stirring to avoid local oversaturation.

3c. Centrifugation

Centrifugation replaces gravity with a much larger effective field. From PHYS201, centripetal acceleration is ω²r. Normalized to g, this gives the relative centrifugal force:

RCF (× g) = 1.118 × 10⁻⁵ · r · N²

  r = radius from rotor axis (cm)
  N = rotor speed (rpm)

Example: r = 10 cm, N = 12 000 rpm  →  RCF ≈ 16 100 × g

Always report g-force, not rpm. "12 000 rpm" is meaningless without the rotor radius. Sedimentation velocity depends on particle mass, density difference from solvent, and shape (the frictional coefficient). Cell debris pellets at a few thousand × g, membranes and ribosomes need ~100 000 × g, and soluble proteins stay in solution.

3d. Dialysis

Dialysis is passive diffusion across a semipermeable membrane with a molecular-weight cutoff (MWCO). Small solutes (salt, imidazole) equilibrate. Macromolecules are retained. It is an equilibrium process, not a pump, so each buffer change dilutes the small solute by a factor set by the volumes:

Residual fraction after n buffer changes (assuming equilibrium each time):

    f = [ Vₛ / (Vₛ + V_b) ]ⁿ

  Vₛ = sample volume,  V_b = dialysis buffer volume

Example: 5 mL sample, 500 mL buffer, 3 changes
    f = (5/505)³ ≈ 9.7 × 10⁻⁷   (~a millionfold reduction)

Three things to watch:

  • Choose the MWCO conservatively. Use roughly half the protein's molecular weight or less, because the cutoff is a nominal, statistical value.
  • Expect volume changes. Dialyzing a high-salt sample into low-salt buffer draws water into the bag osmotically, so leave headspace.
  • Charged macromolecules distort ion distributions. The Donnan effect means small ions do not distribute exactly equally across the membrane.

4. Immobilized Metal Affinity Chromatography (IMAC)

IMAC is coordination chemistry put to work. The imidazole side chain of histidine is an excellent ligand for borderline transition-metal ions such as Ni2+ and Co2+. The method was introduced by Porath and colleagues [Porath et al., 1975]. It became the workhorse of recombinant protein purification once the nitrilotriacetic acid (NTA) chelator and the hexahistidine tag were paired [Hochuli et al., 1988].

The coordination geometry

  • Ni2+ prefers octahedral coordination, with six sites.
  • NTA is tetradentate, occupying four sites and anchoring the metal tightly to the resin.
  • That leaves two sites free to bind His imidazole nitrogens.
  • A His6 tag provides multiple adjacent imidazoles. Their combined binding (avidity) makes the tag bind far more tightly than isolated surface histidines on host proteins.

The logic of binding, washing, and eluting

The imidazole nitrogen must be deprotonated to coordinate a metal. The His side chain has a pKa of about 6, so binding is done near pH 7.5–8. Elution can use any of three approaches:

  1. Competition: high free imidazole (typically 250–500 mM) outcompetes the tag. Low imidazole (10–40 mM) in the binding and wash buffers suppresses weak, nonspecific binders.
  2. Protonation: lowering the pH to ~4.5 protonates the imidazoles and releases them.
  3. Stripping: EDTA removes the metal entirely, along with your protein.
Resin–NTA–Ni²⁺(H₂O)₂ + Protein–His₆   ⇌   Resin–NTA–Ni²⁺(His₆–Protein) + 2 H₂O

Elution by competition:
Resin–NTA–Ni²⁺(His₆–Protein) + n Imidazole  ⇌  Resin–NTA–Ni²⁺(Imidazole)ₙ + Protein–His₆

Incompatibilities that follow from the chemistry:

  • EDTA and EGTA strip the metal.
  • DTT and other strong reductants can reduce Ni2+. The resin turns brown, and binding capacity drops.

Many IMAC buffers tolerate low concentrations of β-mercaptoethanol or TCEP, but check your resin's specifications. High NaCl (300–500 mM) is usually included to suppress ionic nonspecific binding. Unlike ion exchange, IMAC is not disrupted by salt, because its binding is coordinative, not electrostatic.

IMAC is the point at which genetic engineering and inorganic chemistry shake hands. You wrote six histidine codons into a plasmid (BIOL201) so that a Ni2+ ion (CHEM101 ligand-field ideas) would pick your protein out of the entire E. coli proteome.

Even so, IMAC eluates are rarely pure. Host proteins with histidine clusters co-purify. In E. coli, SlyD is a notorious example. This is why IMAC is typically followed by an orthogonal step.


5. Ion-Exchange Chromatography

Charge as a function of pH

A protein's net charge is the sum over all ionizable groups, each following Henderson–Hasselbalch (CHEM102):

For an acidic group (Asp, Glu, C-terminus, Tyr, Cys):
    fraction deprotonated = 1 / (1 + 10^(pKa − pH))     → contributes −1 when deprotonated

For a basic group (Lys, Arg, His, N-terminus):
    fraction protonated   = 1 / (1 + 10^(pH − pKa))     → contributes +1 when protonated

Net charge Z(pH) = Σ(+ contributions) − Σ(− contributions)
pI = pH at which Z = 0

The rule follows directly:

  • pH > pI: the protein is net negative and binds an anion exchanger. Examples are Q (quaternary ammonium, "strong") and DEAE (diethylaminoethyl, "weak").
  • pH < pI: the protein is net positive and binds a cation exchanger. Examples are SP (sulfopropyl, "strong") and CM (carboxymethyl, "weak").

"Strong" and "weak" refer to whether the resin's charge stays constant across the working pH range, not to binding strength. A weak exchanger such as DEAE (pKa ~9–10) begins to lose charge as pH approaches its pKa.

Elution: salt competition and pH

Bound proteins are displaced by raising salt concentration. Cl− or Na+ ions compete for the charged resin sites. Proteins with more charge contacts need more salt to elute. This gives two elution modes:

  • Step elution: discrete jumps in [NaCl], such as 100, 250, and 500 mM. It is fast, concentrates the protein, and suits routine, optimized preps.
  • Gradient elution: a linear increase, for example 0 → 1 M NaCl over 20 column volumes. Resolution is higher, so it suits method development and separating closely related species. Shallower gradients improve resolution but dilute the peaks.

A subtle but important point: retention is not determined by net charge alone. It depends on the distribution of charge, especially charged patches on the face that contacts the resin. A protein can bind an anion exchanger at a pH slightly below its pI if it has a concentrated negative patch. Use the pI rule as a starting guess, not a law.

Choosing the buffer: work about 1 pH unit away from the pI. Use a buffer whose charged form will not itself bind the resin. Tris (cationic) is used with anion exchangers, and MES or phosphate with cation exchangers. Load at low ionic strength, which is often why a dialysis or desalting step comes before ion exchange.


6. Size-Exclusion Chromatography (Gel Filtration)

SEC is the only chromatography in this course in which the protein ideally does not interact with the stationary phase at all. The column contains porous beads. Small molecules explore the pore volume, take a longer path, and elute late. Large molecules are excluded from the pores and elute early.

Picture a crowd walking through a forest. Children (small molecules) wander between all the trees and take a long time to exit. Elephants (large proteins) can't fit between the trees and walk straight along the main path. So in SEC, big comes out first, the reverse of the intuition from SDS-PAGE, where big moves slowest.

Molecular-weight estimation

Define the partition coefficient using the void volume V0 (measured with Blue Dextran, ~2 MDa) and the total column volume Vt:

K_av = (V_e − V₀) / (V_t − V₀)

  V_e = elution volume of the protein
  V₀  = void volume (totally excluded molecule)
  V_t = total bed volume

Empirically, over the fractionation range:
  K_av ≈ a − b · log(MW)        (calibrate with standards of known MW)

This approach to MW estimation was established by Andrews [Andrews, 1964]. The critical caveat is that SEC separates by hydrodynamic (Stokes) radius, not mass. An elongated or partially unfolded protein elutes earlier than a globular protein of the same mass and so appears "heavier." The calibration assumes your protein has the same shape as the globular standards.

This limitation is also SEC's greatest power. Compare the SEC apparent MW with the SDS-PAGE subunit MW and you learn oligomeric state. A 30 kDa band on SDS-PAGE that elutes at ~60 kDa on SEC suggests a dimer.

Practical constraints:

  • Resolution depends heavily on sample volume. Load roughly 0.5–2% of the column volume for high-resolution work.
  • The sample is always diluted.
  • SEC is typically the last step ("polishing"). It removes aggregates and exchanges the protein into its final buffer at the same time.

7. SDS-PAGE: Making Every Protein Look the Same Except Size

The core idea: removing two variables

Electrophoretic mobility of a native protein depends on charge, size, and shape. SDS-PAGE deliberately eliminates two of these:

  • Shape: heating in SDS, with a reductant such as β-mercaptoethanol or DTT to break disulfides, unfolds proteins into rod-like SDS–polypeptide complexes.
  • Charge: SDS binds at roughly 1.4 g per gram of protein [Reynolds & Tanford, 1970]. That is about one SDS per two residues, which swamps the protein's intrinsic charge and gives a near-constant charge-to-mass ratio.

Only size is left. The polyacrylamide mesh acts as a molecular sieve, giving the empirical relationship:

log(MW) ≈ m · R_f + b

  R_f = (distance migrated by band) / (distance migrated by dye front)
  Calibrate with a ladder of known MW; valid within the linear range of the gel %.

The Laemmli discontinuous system: a beautiful trick

Laemmli's system [Laemmli, 1970] uses a stacking gel (low %T, pH 6.8) on top of a resolving gel (higher %T, pH 8.8), with Tris–glycine running buffer. This is the part most students memorize without understanding:

  1. In the stacking gel at pH 6.8, glycine is mostly zwitterionic (net charge ~0), so it moves slowly. Chloride (from Tris-HCl in the gel) is highly mobile.
  2. The SDS–protein complexes have intermediate mobility. They become trapped between the fast Cl− "leading ion" front and the slow glycinate "trailing ion" front.
  3. This isotachophoresis compresses even a large sample volume into a band only micrometers thick.
  4. At the stacking/resolving boundary, the pH jumps to 8.8. Glycine becomes anionic and fast, overtakes the proteins, and releases them. The proteins now separate purely by sieving in the denser resolving gel.
The stacking gel works like a funnel that turns a sloppy, 20 µL sample into a razor-thin starting line. The razor-sharp bands you see come from that funnel, not from loading carefully.

Gel chemistry

  • Polymerization: acrylamide and bis-acrylamide (the cross-linker) undergo free-radical polymerization. Ammonium persulfate (APS) is the radical source, and TEMED catalyzes radical formation. Dissolved O2 is a radical scavenger that inhibits polymerization, which is why you degas and overlay the resolving gel with isopropanol or water.
  • Pore size: higher %T gives smaller pores and resolves smaller proteins. A 15% gel suits 10–60 kDa, and an 8% gel suits 50–200 kDa.
  • Safety: acrylamide monomer is a neurotoxin. Polymerized gel is far less hazardous, but handle unpolymerized solutions with gloves.

Staining

  • Coomassie R-250 or G-250: the same dye family as the Bradford assay. Detection is in the tens-of-nanograms range per band. Staining is quantitative over a moderate range and compatible with mass spectrometry.
  • Silver staining: Ag+ binds protein groups and is then reduced to metallic silver, as in photographic development. It is ~10–100× more sensitive (low-ng range). However, it is less linear, more variable between proteins, and many protocols (especially those using glutaraldehyde) are incompatible with mass spectrometry.

8. Western Blotting: Adding Identity to Size

SDS-PAGE tells you "there is a ~45 kDa band." A Western blot tells you "the ~45 kDa band is protein X," because an antibody recognizes it. The method was established by Towbin and colleagues [Towbin et al., 1979].

The steps and the reasoning behind each

  1. Transfer. Proteins are electrophoresed out of the gel, perpendicular to its face, onto a membrane. Towbin buffer is 25 mM Tris, 192 mM glycine, and 20% methanol. Methanol helps strip SDS and promotes protein binding to the membrane, but it shrinks the gel and can hinder elution of large proteins.
    • Nitrocellulose: binds protein by hydrophobic and other noncovalent interactions.
    • PVDF: more hydrophobic, mechanically robust, higher binding capacity. It must be pre-wetted in methanol, because a dry PVDF membrane is hydrophobic and will not wet in aqueous buffer.
  2. Blocking. The membrane binds protein everywhere, including antibodies. Blocking saturates the unoccupied sites with irrelevant protein, usually 5% non-fat milk or BSA, often with Tween-20. Without blocking, the whole membrane lights up.
  3. Primary antibody. This binds the target epitope. Because the protein was denatured, the antibody must recognize a linear epitope or one that refolds on the membrane. Antibodies raised against native conformational epitopes often fail on Westerns.
  4. Secondary antibody. This is an anti-species antibody, such as goat anti-rabbit IgG, conjugated to horseradish peroxidase (HRP) or a fluorophore. It amplifies signal (several secondaries bind each primary) and makes the system modular.
  5. Detection by enhanced chemiluminescence (ECL). HRP plus H2O2 oxidizes luminol to an excited-state 3-aminophthalate, which emits light at ~425 nm as it relaxes. This is the photophysics of CHEM303, here in an enzymatic setting.
Luminol + H₂O₂  ──(HRP, enhancer)──▶  3-aminophthalate*  ──▶  3-aminophthalate + hν (≈ 425 nm)

Quantitation pitfalls:

  • Chemiluminescent signal saturates film and detectors quickly, and HRP activity decays over time. The linear dynamic range is narrow, so semi-quantitative claims require dilution series and normalization.
  • Normalize to a loading control, or better, to total-protein stain.
  • For phospho-specific antibodies, avoid milk. Casein is a phosphoprotein and will compete.
  • For streptavidin detection, avoid milk too, because it contains biotin.

9. ELISA: Antibodies in a Plate, Read Like a Calibration Curve

The enzyme-linked immunosorbent assay [Engvall & Perlmann, 1971] replaces the gel and membrane with a plastic microplate well. Proteins adsorb to polystyrene. Antibody binding is linked to an enzyme (HRP or alkaline phosphatase) that converts a substrate into colored, fluorescent, or luminescent product. With the HRP substrate TMB, the reaction is stopped with acid and read at 450 nm.

The three formats

  • Direct: antigen coated on the well, detected by an enzyme-labeled primary antibody. It is simple and fast, with no secondary cross-reactivity, but sensitivity is lower.
  • Indirect: antigen coated, unlabeled primary, then an enzyme-labeled secondary. Signal is amplified and the system is flexible. This is the classic format for detecting antibodies in serum.
  • Sandwich: a capture antibody is coated, antigen binds, and a detection antibody binds a different epitope. It needs a matched antibody pair, but it is highly specific (two epitopes must both match) and very sensitive. It works on complex samples like serum because the capture antibody purifies the antigen in the well.

Standard curves and sensitivity

Binding saturates, so ELISA standard curves are sigmoidal on a log-concentration axis. They are fitted with a four-parameter logistic (4PL) model:

y = D + (A − D) / [1 + (x / C)^B]

  A = response at zero concentration (bottom)
  D = response at infinite concentration (top)
  C = inflection point (EC₅₀ of the standard curve)
  B = slope factor (Hill-like)

Limit of detection (common definition):
  LOD = mean(blank) + 3·SD(blank)       → converted to concentration via the curve

This is CHEM302 calibration applied to biology. Only interpolate within the quantifiable range. The plateaus at the ends carry almost no concentration information, because a large change in x produces a tiny change in y.

A counterintuitive phenomenon, the hook effect: in one-step sandwich assays, extremely high antigen concentrations saturate both capture and detection antibodies separately, so fewer sandwiches form. The signal falls, and a huge concentration can read as a moderate one. Diluting the sample, which should reduce the signal, instead increases it. This is the diagnostic clue.


10. Enzyme Kinetics: Km and Vmax by Nonlinear Regression

The model

Consider the simplest scheme, E + S ⇌ ES → E + P. Applying the steady-state approximation, d[ES]/dt ≈ 0 [Briggs & Haldane, 1925], an extension of the original Michaelis–Menten treatment [Michaelis & Menten, 1913], gives:

         k₁           k_cat
E + S  ⇌   ES   ──▶   E + P
         k₋₁

v₀ = V_max · [S] / (K_m + [S])

  K_m   = (k₋₁ + k_cat) / k₁
  V_max = k_cat · [E]_total
  k_cat / K_m = specificity constant (apparent second-order rate constant at low [S])

Interpret Km carefully. It is the substrate concentration giving half-maximal velocity. It equals the dissociation constant of ES only when kcat ≪ k−1. In general it is a kinetic constant, not a thermodynamic affinity.

Experimental design

  • Measure initial rates. Use the linear early part of the progress curve, typically under ~10% substrate consumption, so that [S] ≈ [S]0, product inhibition is negligible, and the reverse reaction is insignificant.
  • Span the curve. Use substrate concentrations from roughly 0.2 Km to 5 Km or higher. Without points near saturation, Vmax is poorly determined. Without points below Km, Km is poorly determined.
  • Keep enzyme dilute. [E] should be ≪ [S], an assumption of the derivation.
  • Control the conditions. Keep temperature, pH, and ionic strength constant. Run no-enzyme controls for non-enzymatic background.

Why nonlinear regression beats Lineweaver–Burk

The double-reciprocal transformation [Lineweaver & Burk, 1934] linearizes the equation:

1/v₀ = (K_m / V_max) · (1/[S]) + 1/V_max

It distorts the error structure (MATH201). The lowest-[S] points have the smallest velocities, and therefore the largest relative errors. Taking reciprocals sends them farthest out on the x-axis, where they exert the most leverage on the fitted line. Ordinary least squares assumes uniform, normally distributed errors, and the transformation violates this badly. Direct nonlinear least-squares fitting of v0 versus [S] to the hyperbola weights the data appropriately and gives honest parameter uncertainties. Use Lineweaver–Burk plots for visualizing inhibition patterns, never for estimating parameters.


11. Inhibition: IC50 Is Not Ki

Mechanistic models

Competitive (I binds free E only):
    v₀ = V_max[S] / ( K_m(1 + [I]/K_i) + [S] )         → apparent K_m increases; V_max unchanged

Uncompetitive (I binds ES only):
    v₀ = V_max[S] / ( K_m + [S](1 + [I]/K_i') )        → apparent K_m and V_max both decrease

Mixed (I binds E with K_i and ES with K_i'):
    v₀ = V_max[S] / ( K_m(1 + [I]/K_i) + [S](1 + [I]/K_i') )
    Noncompetitive is the special case K_i = K_i'      → V_max decreases; K_m unchanged

IC50 and why it depends on conditions

The IC50 is the inhibitor concentration that reduces activity by 50% under specific assay conditions. It is obtained by fitting a dose–response curve (activity versus log[I]), usually a Hill-type or 4PL model like the ELISA one. The key insight is that IC50 is an operational quantity. Ki is a thermodynamic constant. For a competitive inhibitor, the substrate fights the inhibitor for the same site, so more substrate means more inhibitor is needed:

Cheng–Prusoff relationships  [Cheng & Prusoff, 1973]:

  Competitive:      K_i = IC₅₀ / (1 + [S]/K_m)
  Uncompetitive:    K_i' = IC₅₀ / (1 + K_m/[S])
  Noncompetitive:   K_i = IC₅₀   (independent of [S])

Implication: if you run a competitive inhibition assay at [S] = Km, then IC50 = 2Ki. Reporting an IC50 without [S] and Km is like reporting a boiling point without the pressure.

Tight-binding caveat: the Cheng–Prusoff equations assume free [I] ≈ total [I]. If Ki is comparable to the enzyme concentration, a significant fraction of the inhibitor is bound, and the IC50 cannot fall below about [E]/2. Here you must use the Morrison quadratic equation [Copeland, 2005]. Very potent inhibitors often appear to "plateau" at an IC50 near half the enzyme concentration. The assay is reporting [E], not the inhibitor's potency.


12. Circular Dichroism: Reading Secondary Structure from Polarized Light

The physical principle

Chiral molecules absorb left- and right-circularly polarized light differently. CD measures that difference:

ΔA = A_L − A_R          (and Δε = ε_L − ε_R)

Instruments usually report ellipticity θ (in millidegrees):
    θ (degrees) = 32.98 · ΔA

Mean residue ellipticity (normalizes for concentration, path, and length):
    [θ]_MRW = (θ_obs · MRW) / (10 · l · c)

  θ_obs = observed ellipticity (degrees)
  MRW   = mean residue weight = MW / (N − 1)   (N = number of residues; ~110 Da typical)
  l     = path length (cm)
  c     = concentration (g/mL)
  [θ]   in units of deg · cm² · dmol⁻¹

In the far UV (~190–250 nm), the chromophore is the peptide bond itself. Its n→π* transition is near 220 nm, and its π→π* transition is near 190 nm and is split by exciton coupling in ordered structures. Individual amide groups are only weakly chiral, but in an α-helix or β-sheet they are held in regular, chiral arrays. Their transition dipoles couple, which is the coupled-oscillator idea from CHEM303, and each secondary structure produces a characteristic spectrum [Greenfield, 2006; Kelly et al., 2005]:

  • α-helix: strong negative bands at ~222 nm and ~208 nm, and a strong positive band at ~190–193 nm. This is the unmistakable "W" shape.
  • β-sheet: a single negative band near ~216–218 nm and a positive band near ~195–198 nm. Signals are weaker and more variable than for helices.
  • Disordered ("random coil"): a strong negative band near ~195–200 nm and little signal above 210 nm.

Estimation as linear algebra

To a first approximation, the observed spectrum is a linear combination of basis spectra:

θ_obs(λ) ≈ f_α · θ_α(λ) + f_β · θ_β(λ) + f_turn · θ_turn(λ) + f_coil · θ_coil(λ)

subject to  Σ fᵢ = 1,  fᵢ ≥ 0

In matrix form:   θ = B · f    → solve for f by (constrained) least squares

This is MATH301 in action: an overdetermined system (many wavelengths, few unknowns) solved by least squares, with more sophisticated algorithms using reference protein databases and singular value decomposition. Programs such as CONTIN, SELCON, and CDSSTR (accessible through servers like DichroWeb) implement these methods. A common single-wavelength estimate of helix content uses [θ]222, but treat it as rough.

Practical constraints rooted in the physics:

  • Buffers must be transparent in the far UV. Chloride, imidazole, DTT, and high concentrations of many buffers absorb strongly below ~200 nm. Use phosphate or fluoride salts. This is one more reason the dialysis step matters.
  • Keep total absorbance roughly below 1. Otherwise too little light reaches the detector and the signal becomes noise. Watch the HT (detector high-voltage) trace.
  • Accurate concentration is essential. Every error in c propagates directly into [θ] and the secondary-structure fractions, which brings you back to Section 2.
  • CD gives global averages, not residue-level detail. It is excellent for comparing folded and unfolded states, detecting conformational change on ligand binding, and following thermal denaturation (monitor [θ]222 versus temperature to extract a Tm).

13. How the Pieces Fit: The Workflow as a Single Experiment

Consider a typical semester project: express a His-tagged enzyme in E. coli and characterize it. Every technique has a place:

  1. Lyse and clarify: lyse cells, centrifuge, and measure total protein (Bradford or BCA) and activity in the crude extract.
  2. Capture: IMAC. Run SDS-PAGE of load, flow-through, wash, and elution fractions.
  3. Desalt: dialyze to remove imidazole and lower ionic strength.
  4. Intermediate purification: ion exchange with a gradient. Use SDS-PAGE to pick fractions.
  5. Polish: SEC, which removes aggregates and estimates oligomeric state.
  6. Confirm identity: Western blot with anti-His or target-specific antibody.
  7. Quantify precisely: A280 with the computed ε, then build the purification table.
  8. Characterize function: determine Km, Vmax, and kcat by nonlinear regression, then IC50 and Ki for an inhibitor.
  9. Characterize structure: use CD to confirm a folded protein with the expected secondary structure and to determine Tm.
  10. Optional quantitation in complex samples: use a sandwich ELISA.

Notice that each step validates the previous ones. SDS-PAGE checks chromatography. The purification table checks that you are enriching activity, not just a band. CD checks that your "pure" protein is actually folded. This is the scientific habit the course is trying to build: every claim is cross-examined by an orthogonal measurement.


14. Connections to Peptide Chemistry

Peptides, roughly 2–50 residues and often made synthetically by solid-phase peptide synthesis, sit between small organic molecules (CHEM201/202) and proteins (CHEM401). Almost every technique in this course changes behavior, sometimes dramatically, when you move to peptides. Understanding why deepens your grasp of the methods themselves.

  • Quantification breaks down in revealing ways.
    • Many therapeutic and research peptides contain no Trp or Tyr, so A280 is useless.
    • Peptide chemists instead measure absorbance of the peptide bond at 205 or 214 nm. Scopes' A205 method exploits the fact that peptide-bond absorbance is far less sequence-dependent than aromatic absorbance [Scopes, 1994].
    • The Bradford assay responds poorly to small peptides, roughly below ~3 kDa, because stable dye binding seems to require a minimum size and Arg/Lys content.
    • BCA works better because of its peptide-bond contribution.
    • Lyophilized peptides carry counter-ions, often trifluoroacetate from HPLC, and bound water. Weighed mass therefore overestimates peptide content. Amino acid analysis is the gold standard.
  • SDS-PAGE needs modification. Small peptides migrate anomalously and resolve poorly in Laemmli gels, partly because they co-migrate with the SDS micelle and glycine front. Tricine–SDS-PAGE replaces glycine with tricine as the trailing ion and improves resolution below ~10 kDa [Schägger & von Jagow, 1987]. For truly short peptides, reverse-phase HPLC and mass spectrometry replace gels entirely.
  • CD is a primary tool for peptide conformation.
    • Short peptides are often disordered in water. Their helicity can be induced by trifluoroethanol, by membrane mimetics such as SDS micelles, or by design (helix-capping motifs, Ala-rich sequences, side-chain "staples").
    • [θ]222 is the standard readout for percent helicity of designed and antimicrobial peptides.
    • The normalization by mean residue weight becomes critical here, because end effects matter more in short chains.
  • Inhibition assays are where peptides become drugs. Peptide inhibitors and substrate analogues are classic competitive inhibitors, so Cheng–Prusoff analysis applies directly. Many protease inhibitors began as peptide mimics of substrate sequences. Potent macrocyclic peptides are often tight binders, so the Morrison treatment matters.
  • Antibody methods meet peptides through epitopes. Anti-peptide antibodies are raised against short synthetic sequences conjugated to carrier proteins such as KLH. Because these antibodies recognize linear epitopes, they often perform well on Western blots of denatured protein. Peptide-coated ELISA plates are used for epitope mapping. The His6 tag is itself a peptide epitope, recognized by anti-His antibodies.
  • IMAC reappears in peptide analytics.
    • The His-tag is a designed peptide ligand for a metal.
    • Fe3+ or Ga3+ IMAC, and related metal-oxide chemistry such as TiO2, enrich phosphopeptides from proteolytic digests in phosphoproteomics. This uses the same coordination principle with a different ligand: phosphate instead of imidazole.
    • Tags are often removed by a site-specific protease such as TEV, which recognizes a short peptide sequence and leaves a residual scar of a residue or two.
  • Ion exchange and pI calculations transfer directly. For peptides, terminal charges contribute proportionally more to the net charge. N-terminal acetylation and C-terminal amidation, common modifications in synthetic peptides, shift the pI noticeably.

Looking ahead: the logic you learn here (separate, quantify, validate orthogonally) is the same logic used in peptide drug development, proteomics (digest proteins into peptides, separate them, identify them by mass spectrometry), and protein engineering. You will meet it again in any course on biophysical chemistry, peptide synthesis, or structural biology.


15. Common Misconceptions to Watch Out For

  1. "Bradford, BCA, and A280 should agree if I did them right." They measure different chemical features and are referenced to different standards. Disagreements of 20–50% between assays are common and often reflect composition, not error.
  2. "A single band on a Coomassie gel means my protein is pure." It means no contaminant is present above roughly tens of ng, at a different size, under denaturing conditions. Co-migrating contaminants, nucleic acids, aggregates, and misfolded protein are all invisible here. Purity claims need orthogonal evidence: SEC, activity, A260/A280, or mass spectrometry.
  3. "SEC gives the molecular weight." SEC reports the hydrodynamic radius relative to globular standards. Elongated, flexible, or glycosylated proteins give inflated apparent MWs.
  4. "SDS-PAGE MW is exact." Highly charged, proline-rich, membrane, or glycosylated proteins bind SDS atypically and migrate anomalously, sometimes by 10–20% or more.
  5. "Proteins bind anion exchangers only above their pI." Charge distribution, not just net charge, governs binding. Use the pI rule as a starting point.
  6. "Km is the binding affinity." Km equals Kd of the ES complex only when kcat ≪ k−1. In general it is a composite kinetic constant.
  7. "Lineweaver–Burk is the standard way to get Km and Vmax." It is a visualization tool that distorts errors. Fit the untransformed data by nonlinear regression.
  8. "IC50 and Ki are interchangeable." IC50 depends on [S] (for competitive and uncompetitive inhibitors) and on [E] (for tight binders). Ki is the intrinsic constant. Always report the assay conditions with an IC50.
  9. "Darker Western bands mean proportionally more protein." Chemiluminescence saturates and has a narrow linear range. Without a dilution series and proper normalization, band intensity is at best semi-quantitative.
  10. "More imidazole in the IMAC wash is always better for purity." Past a point, you strip your own target. The optimal wash is a balance found empirically for each protein.
  11. "Dialysis removes salt completely." It is an equilibrium dilution. Residual concentration depends on volume ratios and number of exchanges, and osmotic volume changes can surprise you.
  12. "CD tells me the protein's structure." CD gives a global estimate of secondary-structure fractions, with typical uncertainties of several percent and poorer accuracy for β-rich proteins. It cannot tell you which residues are helical or anything about tertiary structure, except indirectly through near-UV CD.
  13. "rpm is a fine way to report centrifugation." Only RCF (× g) is transferable between rotors.
  14. "Higher signal in ELISA always means more analyte." In one-step sandwich formats, the hook effect can make very high concentrations read low. Dilution linearity tests catch this.
The deepest lesson of this lab is that every number you produce comes from a specific physical interaction, and every interaction has failure modes. A biochemist becomes trustworthy by learning to ask, for every measurement, "What exactly did this instrument see, and what else could have produced the same signal?"

References Cited

  • Andrews, P. (1964). Estimation of the molecular weights of proteins by Sephadex gel-filtration. Biochem. J. 91, 222–233.
  • Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254.
  • Briggs, G. E. & Haldane, J. B. S. (1925). A note on the kinetics of enzyme action. Biochem. J. 19, 338–339.
  • Cheng, Y. & Prusoff, W. H. (1973). Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099–3108.
  • Copeland, R. A. (2005). Evaluation of Enzyme Inhibitors in Drug Discovery. Wiley-Interscience.
  • Elliott, W. H. & Elliott, D. C. (2009). Biochemistry and Molecular Biology Laboratory Manual, 4th ed. Oxford University Press. (Course text as assigned.)
  • Engvall, E. & Perlmann, P. (1971). Enzyme-linked immunosorbent assay (ELISA): quantitative assay of immunoglobulin G. Immunochemistry 8, 871–874.
  • Greenfield, N. J. (2006). Using circular dichroism spectra to estimate protein secondary structure. Nat. Protoc. 1, 2876–2890.
  • Hochuli, E., Bannwarth, W., Döbeli, H., Gentz, R. & Stüber, D. (1988). Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent. Bio/Technology 6, 1321–1325.
  • Kelly, S. M., Jess, T. J. & Price, N. C. (2005). How to study proteins by circular dichroism. Biochim. Biophys. Acta 1751, 119–139.
  • Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685.
  • Lineweaver, H. & Burk, D. (1934). The determination of enzyme dissociation constants. J. Am. Chem. Soc. 56, 658–666.
  • Michaelis, L. & Menten, M. L. (1913). Die Kinetik der Invertinwirkung. Biochem. Z. 49, 333–369.
  • Pace, C. N., Vajdos, F., Fee, L., Grimsley, G. & Gray, T. (1995). How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4, 2411–2423.
  • Porath, J., Carlsson, J., Olsson, I. & Belfrage, G. (1975). Metal chelate affinity chromatography, a new approach to protein fractionation. Nature 258, 598–599.
  • Reynolds, J. A. & Tanford, C. (1970). Binding of dodecyl sulfate to proteins at high binding ratios. Proc. Natl. Acad. Sci. USA 66, 1002–1007.
  • Schägger, H. & von Jagow, G. (1987). Tricine–sodium dodecyl sulfate–polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166, 368–379.
  • Scopes, R. K. (1994). Protein Purification: Principles and Practice, 3rd ed. Springer-Verlag.
  • Smith, P. K. et al. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76–85.
  • Towbin, H., Staehelin, T. & Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350–4354.

⚙️ Mechanisms & Applications

GPT-6 Astra

Mechanisms & Applications: Following a Protein from Mixture to Meaning

Skipper, the organizing question of this laboratory is not simply “Can I detect a protein?” It is: What evidence shows that I have the intended molecule, in the intended amount, with the intended structure and function? These are separate claims. A strong absorbance signal does not establish identity; a single electrophoretic band does not establish activity; antibody recognition does not establish correct folding.

The intellectual connection to analytical chemistry is especially important: every method converts a molecular property into an observable signal. Understanding the conversion mechanism tells us both what the measurement means and how it can mislead us. Protein purification then becomes a sequence of deliberately chosen measurements and separations, rather than a collection of recipes.[1]

Biological mixture
    ↓ extract while preserving the target
Clarified sample
    ↓ separate by solubility, affinity, charge, and/or size
Enriched protein
    ↓ quantify and assess purity
Characterized preparation
    ↓ test identity, folding, and activity
Evidence that the preparation is fit for its intended use

1. Protein Quantification: Three Different Ways to “Count” Protein

The first conceptual trap is to treat “protein concentration” as a directly observed quantity. Usually it is inferred from a response that depends on amino-acid composition, chemical environment, or both. Thus, two assays can disagree without either instrument malfunctioning.

Bradford assay: protein binding changes a dye’s electronic state

  1. Prepare a reagent blank and a series of protein standards, commonly bovine serum albumin, in a matrix that resembles the samples.
  2. Add acidic Coomassie Brilliant Blue G-250 reagent to standards and diluted samples.
  3. Dye association with protein favors the blue anionic form. Binding depends strongly on basic residues, especially arginine, with additional contributions from other interactions.
  4. Measure absorbance near 595 nm after a consistent incubation interval.
  5. Interpolate sample responses within the validated standard-curve range, then correct for dilution.
Within a validated approximately linear interval:

A595 = m c + b

coriginal = [(Asample − b)/m] × dilution factor

Outside that interval:
use a validated nonlinear calibration or dilute and remeasure.

The assay introduced by Marion Bradford in 1976 made rapid, small-volume protein measurement widely accessible.[2] Its convenience hides an important limitation: a BSA calibration measures the concentration of another protein accurately only to the extent that the proteins have comparable dye responses. A result may therefore be better understood as a BSA-equivalent concentration.

Application to peptide development: small peptides can respond weakly or inconsistently because they lack sufficient favorable binding sites. A Bradford result near zero does not establish that a peptide is absent. Detergents can also perturb the assay, so a buffer-compatible blank alone does not replace an interference test.

BCA assay: copper reduction followed by colored complex formation

  1. Under alkaline conditions, protein-associated chemistry reduces Cu2+ to Cu+.
  2. Peptide bonds and particular side chains contribute to the response; it is not a perfectly uniform reaction per gram of protein.
  3. Two bicinchoninic acid molecules coordinate each Cu+, producing a purple complex.
  4. Measure absorbance near 562 nm against standards processed at the same temperature and incubation time.
Protein-dependent reaction:
Cu2+ → Cu+

Color formation:
Cu+ + 2 BCA → colored Cu(I)–BCA complex

Smith and colleagues introduced the BCA protein assay in 1985.[3] It is often more compatible with detergents than Bradford assays, but reducing agents can generate Cu+ independently of protein, while chelators can interfere with copper chemistry. This is a direct application of CHEM102 redox and coordination chemistry: anything that participates in the indicator reaction can impersonate or suppress the analyte.

Absorbance at 280 nm: use the protein’s own chromophores

Tryptophan and tyrosine dominate most protein absorbance at 280 nm, with a smaller contribution from cystine. Unlike dye-based assays, this approach can be nondestructive and require no added reagent. It is particularly useful for sufficiently pure proteins with known sequences.[4]

Beer–Lambert law:

A280 = ε280 l c

c = A280/(ε280 l)

A280: dimensionless absorbance
ε280: molar extinction coefficient, M−1 cm−1
l: optical path length, cm
c: molar concentration, M

A commonly used sequence-based estimate is:

ε280 ≈ 5500 nTrp + 1490 nTyr + 125 ncystine

Here ncystine counts disulfide bonds, not individual cysteine residues.

For example, if ε280 = 30,000 M−1 cm−1, the path length is 1.00 cm, and A280 = 0.600, the protein concentration is 20.0 µM. For a 50,000 g mol−1 protein, that corresponds to 1.00 mg mL−1.

  • Purity matters: nucleic acids, other proteins, and some buffer components contribute absorbance.
  • Physical state matters: aggregates scatter light, which can appear as increased absorbance.
  • Sequence matters: an aromatic-poor peptide may have little useful A280. Absorbance at shorter wavelengths can help, but solvent and buffer absorption become more troublesome.
  • Instrument geometry matters: microvolume instruments and plate readers do not necessarily use a 1 cm path; determine whether displayed values are path-length corrected.

Working rule: choose a method by asking which response mechanism is least compromised by this particular molecule and matrix—not which assay is most familiar.

2. Purification Strategy: Preserve Function While Removing Alternatives

A protein preparation is like a crowded room whose occupants differ in several characteristics. Sorting only by height will not isolate one person. Likewise, repeated separations by the same property may give diminishing returns. Effective purification usually combines orthogonal properties: affinity, charge, and hydrodynamic size.[1]

Before beginning, define the target’s stability window: pH, ionic strength, temperature, redox requirements, and dependence on cofactors or binding partners. Cold handling often slows proteolysis and denaturation, but not every protein is cold-stable. A preservation additive must also be compatible with downstream assays and chromatography.

Ammonium sulfate precipitation: changing solubility without intending to unfold

  1. Add ammonium sulfate gradually with mixing, usually while controlling temperature.
  2. At sufficiently high salt concentration, altered solvent conditions and protein–ion interactions make soluble protein less favorable relative to protein–protein association.
  3. Different proteins precipitate over different salt-saturation intervals.
  4. Centrifuge to separate precipitated material from the supernatant.
  5. Assay both fractions until the target’s partitioning is established.
  6. Redissolve the selected precipitate and remove excess salt before incompatible downstream steps.

The familiar explanation that salt “takes water away from the protein” is a useful first analogy, but incomplete. Salting-out reflects thermodynamic changes in hydration and intermolecular interactions, not literal exhaustion of all free water. Low salt can even increase the solubility of some proteins—salting-in—before higher salt promotes precipitation.[1]

A “30–60% cut” means collecting material that precipitates as the solution moves from 30% to 60% ammonium sulfate saturation. It does not mean 30–60% mass/volume salt. Saturation calculations depend on temperature and on salt already present.

Industrial application: precipitation can concentrate large process streams relatively inexpensively before higher-resolution chromatography. The limitation is selectivity: a precipitate is usually an enriched mixture, not a purified product.

Centrifugation: a race governed by mass, buoyancy, and drag

Particles sediment because centrifugal forcing exceeds the opposing effects of buoyancy and friction. Size matters, but so do particle density, shape, and medium viscosity. Insoluble debris can therefore be removed while soluble proteins remain in the supernatant; ordinary clarification is not a method for pelleting every soluble protein.

Relative centrifugal force:

RCF = 1.118 × 10−5 × r × (rpm)²

r: rotor radius in cm
RCF: acceleration expressed relative to g

Reporting only rpm is incomplete because two rotors at the same rotational speed can exert different forces. This is PHYS201 made operational: the radial acceleration is ω²r.

Dialysis: diffusion that exchanges small solutes while retaining protein

  1. Place the sample inside a semipermeable membrane with an appropriate nominal molecular-weight cutoff.
  2. Immerse it in a larger volume of the desired buffer.
  3. Small diffusible solutes approach equal concentrations across the membrane; retained macromolecules remain largely inside.
  4. Replace the external buffer to restore the concentration gradient and continue exchange.
Idealized exchange against initially solute-free external buffer:

Cafter/Cbefore = Vsample/(Vsample + Vbuffer)

After n complete exchanges with fresh buffer:

Cn/C0 = [Vsample/(Vsample + Vbuffer)]n

Assumptions:
complete equilibration, unchanged volumes, freely diffusible solute,
and no binding or membrane retention of that solute.

Dialysis is particularly useful after ammonium sulfate precipitation or when changing assay buffers. Its molecular-weight cutoff is not a sharp molecular sieve. Small peptides may escape, and tightly bound ligands may be removed slowly because only their free fraction can diffuse.

3. Chromatography: Turn a Molecular Property into Differential Travel

IMAC: histidine side chains coordinate immobilized metal ions

Immobilized metal affinity chromatography, developed by Porath and colleagues in 1975, exploited metal-binding differences among proteins before polyhistidine tags became commonplace.[5] In modern His-tag purification, a resin-bound chelator holds Ni2+ or Co2+ while leaving coordination sites available to histidine imidazole groups.

  1. Equilibrate: establish a buffer in which the target is soluble and histidine coordination is favorable.
  2. Load: the His-tagged protein binds through multiple coordination interactions.
  3. Wash: suitable salt and a modest imidazole concentration suppress weak nonspecific retention.
  4. Elute: higher imidazole competes for metal coordination. Lowering pH can also weaken binding by protonating histidine, if the target tolerates it.
  5. Exchange buffer: remove imidazole or other components that interfere with activity assays or formulation.
Conceptual binding competition:

Resin–chelator–metal + His-tagged protein
    ⇌ resin–chelator–metal···His-tagged protein

Increasing free imidazole
    → competition for coordination sites
    → release of bound protein

The important correction: a His tag increases affinity; it does not create absolute specificity. Host proteins with suitable metal-binding surfaces can co-purify, and a buried tag may bind poorly. Strong chelators such as EDTA can strip the immobilized metal, so compatibility must be checked.

Pharma application: IMAC is valuable for recombinant enzymes, screening reagents, and protein constructs used in structural studies. For a therapeutic candidate, the tag may need removal, followed by separation of the cleaved tag, cleavage enzyme, uncleaved target, host contaminants, and any leached metal. Convenient capture is not equivalent to a release-quality drug substance.

Ion exchange: separate proteins by charge under chosen conditions

The names refer to the species retained, not the charge of the resin:

  • Anion exchanger: positively charged resin that binds negatively charged species.
  • Cation exchanger: negatively charged resin that binds positively charged species.
Useful first approximation:

pH > protein pI → net negative protein → consider anion exchange
pH < protein pI → net positive protein → consider cation exchange

But:
surface charge patches, buffer conductivity, and resin chemistry
also determine actual binding.
  1. Choose a pH that gives useful charge while preserving solubility and function.
  2. Reduce sample conductivity if necessary so buffer ions do not prevent binding.
  3. Load and wash the column.
  4. Elute by increasing salt concentration or changing pH.

Salt screens electrostatic interactions and supplies counterions that compete with bound protein. A step elution abruptly changes conditions and is convenient for established processes. A gradient elution changes conditions progressively, often resolving species with similar retention more effectively.[1]

Medical and pharmaceutical application: ion exchange can resolve charge variants of therapeutic proteins. Deamidation, terminal processing, or altered post-translational modifications can change retention even when molecular masses are nearly identical. Charge separation therefore reports chemical heterogeneity that SDS-PAGE may miss.

Size-exclusion chromatography: smaller molecules take the longer route

SEC is counterintuitive at first: large molecules usually emerge before small ones. Large molecules cannot enter many bead pores and travel mainly through the interstitial liquid. Smaller molecules sample more internal pore volume and consequently elute later.

Partition coefficient:

Kav = (Ve − V0)/(Vt − V0)

Ve: analyte elution volume
V0: void volume, measured using an excluded marker
Vt: total accessible liquid volume for a fully included small solute

Within a suitable fractionation range, globular standards often give:

log10(Mr) = a Kav + b

The calibration estimates molecular mass only indirectly. SEC senses hydrodynamic size, not mass itself. An elongated monomer can elute like a heavier globular protein; glycosylation, disorder, aggregation, and unintended resin interactions can also shift elution. A “100 kDa” SEC estimate is therefore not proof of a dimer of a 50 kDa subunit.[1]

Use small sample volumes when resolution matters, and select a resin whose fractionation range covers the target. In biopharmaceutical work, SEC is widely used to assess soluble aggregates and oligomer distributions; in peptide workflows, the pore range must be appropriate for much smaller molecules. Routine SEC calibration alone should not be mistaken for an absolute mass measurement.

4. Quantifying Purification: Follow Activity, Not Merely Protein

For an enzyme, the most useful running record combines protein mass with catalytic activity. Define the activity unit explicitly—for example, 1 U = 1 µmol product formed per minute under specified assay conditions.

Total protein (mg)
    = protein concentration (mg/mL) × volume (mL)

Total activity (U)
    = activity concentration (U/mL) × volume (mL)

Specific activity (U/mg)
    = total activity / total protein

Yield (%) = 100 × activity after step / starting activity

Purification fold
    = specific activity after step / starting specific activity

Suppose the crude extract contains 1,000 mg protein and 5,000 U: its specific activity is 5 U mg−1. A purified fraction contains 50 mg and 2,500 U: its specific activity is 50 U mg−1. This is a tenfold purification with 50% activity yield.

The beautiful tension is that purity and recovery are different objectives. Discarding everything except a tiny active fraction can give impressive purity but a poor process. Conversely, apparent activity recovery above 100% may occur if purification removes an inhibitor or an assay interferent. It is a signal to investigate the measurement model, not evidence that enzyme molecules were created.

5. SDS-PAGE: Replace Native Complexity with a More Uniform Migration Rule

Native proteins differ in charge, shape, and size. SDS-PAGE deliberately suppresses much of this complexity so that migration depends primarily on polypeptide chain size. Laemmli’s 1970 discontinuous electrophoresis system helped establish the widely used modern format.[6]

  1. Prepare the gel: acrylamide and a crosslinker polymerize into a porous network, commonly initiated with ammonium persulfate and accelerated by TEMED. Higher acrylamide content generally produces smaller pores.
  2. Prepare the sample: SDS disrupts many noncovalent interactions and associates with unfolded polypeptides, giving an approximately uniform negative charge-to-mass ratio.
  3. Choose redox conditions: DTT or another suitable reducing agent cleaves disulfide bonds. Comparing reducing and nonreducing samples can reveal disulfide-linked subunits.
  4. Stack: the discontinuous buffer system concentrates sample proteins into a narrow starting zone.
  5. Resolve: proteins migrate through the sieving gel; smaller chains generally move faster.
  6. Visualize: stain with Coomassie or a more sensitive method such as silver staining.
Within a calibrated working range:

Rf = migration distance of protein / migration distance of dye front

log10(Mr) ≈ a − b Rf

Nonpolymerized acrylamide is hazardous and requires appropriate laboratory controls. Gel preparation is chemistry with a safety consequence, not just a casting task.

  • Coomassie staining: useful for routine purity assessment and approximate densitometry within its validated response range.
  • Silver staining: often detects less protein, but response can vary strongly among proteins and can be nonlinear; downstream compatibility depends on the protocol.
  • Interpretive limit: one band can contain multiple co-migrating proteins. Glycoproteins and unusual sequences can show anomalous apparent molecular masses.

Peptide application: very small peptides may migrate with the dye front, diffuse, or stain poorly in standard gels. Tricine-SDS-PAGE, introduced by Schägger and von Jagow, improves resolution of lower-molecular-mass species.[7]

6. Western Blotting and ELISA: Recognition Is Powerful but Conditional

Western blot: separate first, then ask an antibody what it recognizes

  1. Separate sample proteins by electrophoresis.
  2. Electrotransfer proteins onto nitrocellulose or PVDF, preserving their approximate separation pattern.
  3. Block unoccupied membrane sites to reduce nonspecific adsorption.
  4. Incubate with a primary antibody that recognizes a target epitope.
  5. Wash, then add a detection reagent, often an enzyme-conjugated secondary antibody.
  6. Wash again and detect the enzyme-generated signal. In common chemiluminescent systems, horseradish peroxidase catalyzes light-producing substrate chemistry.

Towbin, Staehelin, and Gordon’s 1979 electrotransfer method made electrophoretically resolved proteins accessible to immunological detection.[8] The advance was the combination of two filters: approximate size and molecular recognition.

Neither filter is infallible. SDS treatment can destroy conformational epitopes. Antibodies may cross-react; transfer efficiency can vary with protein size; and overloaded or overexposed signals saturate. A band of the expected size is supporting evidence, not self-validating proof of identity.

Controls that answer different questions: a positive control tests whether detection works; a genetically absent or depleted target can test specificity; a no-primary control probes secondary-reagent background; and total-protein staining or a validated loading reference supports comparisons between lanes. Quantitative comparisons require an unsaturated, validated response range.

ELISA: translate molecular recognition into a calibrated plate signal

Engvall and Perlmann’s 1971 work helped establish enzyme-linked immunosorbent assays as practical alternatives to radiolabeled immunoassays.[9] Enzyme labels offer signal amplification because one bound enzyme can turn over many substrate molecules.

  • Direct ELISA: an immobilized antigen is detected with a labeled antigen-specific antibody.
  • Indirect ELISA: immobilized antigen binds a primary antibody, which is detected by a labeled secondary antibody. This is useful for measuring antigen-specific antibodies in serum.
  • Sandwich ELISA: an immobilized capture antibody binds antigen, and a detection antibody recognizes another accessible epitope. An additional labeled reagent may provide the final signal.
Typical sandwich sequence:

Coat capture antibody
    → block
    → add standards and samples
    → wash
    → add detection antibody
    → wash
    → add label reagent if required
    → wash
    → add substrate
    → measure signal

Many ELISA calibration curves are sigmoidal rather than linear. A common four-parameter logistic form for an increasing response is:

y = bottom + (top − bottom)/[1 + (C50/x)h]

x: analyte concentration
C50: concentration at the response midpoint
h: slope parameter

C50 is a calibration parameter, not automatically an antibody Kd.

Unknowns should be interpolated within the validated range, not extrapolated beyond the standards. Detection limit, quantification limit, and working range are distinct: reliably distinguishing a signal from blank is easier than measuring its concentration with acceptable precision and bias.

Clinical and pharma applications: ELISAs measure hormones, cytokines, pathogen-associated antigens, antibodies, and residual host-cell proteins. Matrix interference and antibody cross-reactivity remain important. Very high antigen concentrations can cause a high-dose hook effect in susceptible sandwich formats; dilution can expose an unexpectedly low result. Small peptides may lack two simultaneously accessible epitopes, making a sandwich format impractical and a competitive assay preferable.

7. Enzyme Kinetics: Measure Rates Before Asking What They Mean

From CHEM401, Skipper already knows that enzymes lower activation barriers without changing reaction equilibrium. The laboratory challenge is to measure a catalytic rate rather than confuse it with an endpoint, optical artifact, or changing substrate concentration.

Minimal Michaelis–Menten mechanism:

E + S ⇌ ES → E + P
      k1, k−1   kcat

v0 = Vmax[S]/(Km + [S])

Vmax = kcat[E]total

Km = (k−1 + kcat)/k1

Michaelis and Menten’s 1913 analysis was foundational, while Briggs and Haldane’s 1925 treatment established the familiar steady-state derivation.[10,11] This distinction matters: Km is not generally a binding dissociation constant. It approaches Kd = k−1/k1 only in the appropriate rapid-equilibrium limit, where catalytic conversion is slow relative to substrate dissociation.

  1. Choose a direct signal or a validated coupled assay that follows substrate loss or product formation.
  2. Keep enzyme concentration fixed while varying substrate concentration over a range that samples curvature and, if feasible, approaches saturation.
  3. Record time courses rather than only final values.
  4. Identify an initial linear interval after mixing artifacts but before substantial substrate depletion, product effects, or enzyme instability.
  5. Subtract appropriate blank rates and convert signal slopes into concentration-change rates.
  6. Fit the original rate data by nonlinear regression and inspect residuals and parameter uncertainty.
For an absorbance assay:

v = |dA/dt|/(|Δε| l)

Δε: extinction-coefficient difference for the monitored conversion

For NADH disappearance at 340 nm, under common assay conditions:
ε340 ≈ 6220 M−1 cm−1

If dA340/dt = −0.0622 min−1 and l = 1.00 cm:

v = 1.00 × 10−5 M min−1 = 10.0 µM min−1

In a 1.00 mL reaction:
activity = 0.0100 µmol min−1 = 0.0100 U

Reaction stoichiometry must be included if one catalytic event consumes or produces more than one monitored molecule. In a coupled assay, the coupling system must be fast enough not to determine the observed rate.

Why nonlinear regression? Reciprocal plots such as Lineweaver–Burk plots distort the error structure and amplify uncertainty at low substrate concentrations. They can illustrate equations, but usually should not be the primary estimation method. Even nonlinear regression cannot rescue an uninformative design: if all substrate concentrations are far below Km, the data mainly constrain Vmax/Km, not the two parameters independently.[13]

Finally, kcat requires the molar concentration of active catalytic sites. Dividing Vmax by total protein concentration gives a misleading turnover number if much of the preparation is inactive or if subunit and active-site stoichiometries are confused.

8. Inhibition Assays: IC50 Is an Experimental Outcome, Not a Universal Constant

  1. Fix substrate, enzyme, solvent, buffer, temperature, and timing conditions.
  2. Measure initial rates across an inhibitor concentration series.
  3. Normalize to matched uninhibited controls after appropriate background correction.
  4. Fit a suitable concentration–response model.
  5. Investigate mechanism before converting the fitted midpoint into a binding or inhibition constant.
A common inhibition-response model:

Activity(I) = bottom + (top − bottom)/[1 + (I/IC50)h]

For reversible, simple competitive inhibition:

v = Vmax[S]/{Km(1 + [I]/Ki) + [S]}

Cheng–Prusoff relation:

Ki = IC50/(1 + [S]/Km)

Cheng and Prusoff formalized the competitive-inhibition relationship in 1973.[12] If [S] = Km, an IC50 of 2 µM corresponds to Ki = 1 µM under the required assumptions. Increasing substrate concentration raises the observed IC50 for a simple competitive inhibitor: the inhibitor did not intrinsically become weaker; the assay became harder to inhibit.

The conversion is not generally valid for tight-binding inhibitors that appreciably deplete free inhibitor, irreversible inhibitors, time-dependent inhibition, or other mechanisms. Slow-binding compounds may show incubation-dependent potency. A fitted Hill slope is also not, by itself, proof of molecular cooperativity.

Drug-discovery application: inhibition assays rank compounds and support structure–activity relationships, including those of peptide inhibitors. But a compound may suppress the assay signal by absorbing light, quenching fluorescence, aggregating, inhibiting a coupling enzyme, or destabilizing the target. Orthogonal readouts and interference controls separate useful pharmacology from attractive-looking artifacts.[13]

9. Circular Dichroism: Detect Structure Through Differential Absorption

CD measures the difference in absorption of left- and right-circularly polarized light. Chiral protein structures give different optical responses to these two forms of light. In the far-UV region, peptide-bond transitions make the spectrum sensitive to secondary structure.[14]

Circular dichroism:

ΔA = Aleft − Aright

Convert measured ellipticity to mean residue ellipticity:

[θ]MR = θobs × MRW / (10 c l)

θobs: ellipticity in millidegrees
MRW: mean residue molecular weight, g mol−1
c: protein concentration, mg mL−1
l: path length, cm

[θ]MR units: deg cm² dmol−1, on a per-residue basis
  1. Choose a buffer with sufficiently low absorbance over the wavelength range of interest.
  2. Determine concentration accurately and use an appropriate quartz cell.
  3. Collect sample and matched buffer spectra under identical conditions.
  4. Check whether strong absorbance, scattering, or instrumental limits compromise the short-wavelength data.
  5. Subtract the buffer baseline and normalize for concentration, path length, and residue content.
  6. Estimate secondary-structure content using a suitable reference set and fitting method.
  • α-helical spectra: typically show negative bands near 208 and 222 nm and a positive band near 190 nm.
  • β-sheet spectra: often show a negative band around 215–218 nm, although sheet spectra vary substantially.
  • Disordered conformations: often produce a strong negative feature near 195–200 nm.

These are characteristic patterns, not unique structural barcodes. Spectral fitting is an inverse problem: several mixtures of conformations may produce similar data, especially over a restricted wavelength interval. CD estimates ensemble-average structure; it does not provide an atomic model.

Peptide and biopharmaceutical application: CD can test whether a designed peptide becomes helical in a membrane-mimicking environment, whether purification preserves a protein’s fold, or whether a formulation changes structural stability. A temperature-dependent signal can define an apparent unfolding midpoint. Interpreting that midpoint as an equilibrium melting temperature requires evidence of reversibility and a defensible unfolding model; aggregation or irreversible change can invalidate thermodynamic analysis.

10. The Integrated Lesson: Make Different Measurements Cross-Examine One Another

Consider a recombinant enzyme intended for inhibitor screening:

  1. Capture by IMAC exploits the engineered tag.
  2. Polish by ion exchange separates proteins or variants with different charge behavior.
  3. Use SEC to assess hydrodynamic homogeneity and remove resolvable soluble aggregates.
  4. Quantify with A280 or a compatible calibrated assay to establish the amount present.
  5. Use SDS-PAGE and Western blotting to assess chain-size distribution and immunological identity.
  6. Use CD to test consistency with the expected secondary structure.
  7. Measure catalytic activity and kinetics to establish whether the preparation performs its intended function.

If SDS-PAGE shows one band but SEC shows several peaks, investigate oligomerization, aggregation, or shape heterogeneity. If a Western blot is positive but activity is absent, the recognized epitope may survive despite loss of catalytic structure. If two concentration assays disagree, ask which measurement chemistry is vulnerable to the sample matrix.

Skipper’s durable takeaway: biochemical understanding grows when measurements disagree and we can explain why. Each technique is a witness with a particular field of view. Confidence comes from agreement among independent witnesses—not from repeating the same kind of evidence.

References

  1. Scopes, R. K. Protein Purification: Principles and Practice. 3rd ed. Springer, 1994.
  2. Bradford, M. M. “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.” Analytical Biochemistry 72 (1976): 248–254. doi:10.1016/0003-2697(76)90527-3.
  3. Smith, P. K., et al. “Measurement of protein using bicinchoninic acid.” Analytical Biochemistry 150 (1985): 76–85. doi:10.1016/0003-2697(85)90442-7.
  4. Pace, C. N., Vajdos, F., Fee, L., Grimsley, G., and Gray, T. “How to measure and predict the molar absorption coefficient of a protein.” Protein Science 4 (1995): 2411–2423. doi:10.1002/pro.5560041120.
  5. Porath, J., Carlsson, J., Olsson, I., and Belfrage, G. “Metal chelate affinity chromatography, a new approach to protein fractionation.” Nature 258 (1975): 598–599. doi:10.1038/258598a0.
  6. Laemmli, U. K. “Cleavage of structural proteins during the assembly of the head of bacteriophage T4.” Nature 227 (1970): 680–685. doi:10.1038/227680a0.
  7. Schägger, H., and von Jagow, G. “Tricine–sodium dodecyl sulfate–polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.” Analytical Biochemistry 166 (1987): 368–379. doi:10.1016/0003-2697(87)90587-2.
  8. Towbin, H., Staehelin, T., and Gordon, J. “Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.” Proceedings of the National Academy of Sciences USA 76 (1979): 4350–4354. doi:10.1073/pnas.76.9.4350.
  9. Engvall, E., and Perlmann, P. “Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.” Immunochemistry 8 (1971): 871–874. doi:10.1016/0019-2791(71)90454-X.
  10. Michaelis, L., and Menten, M. L. “Die Kinetik der Invertinwirkung.” Biochemische Zeitschrift 49 (1913): 333–369.
  11. Briggs, G. E., and Haldane, J. B. S. “A note on the kinetics of enzyme action.” Biochemical Journal 19 (1925): 338–339. doi:10.1042/bj0190338.
  12. Cheng, Y.-C., and Prusoff, W. H. “Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.” Biochemical Pharmacology 22 (1973): 3099–3108. doi:10.1016/0006-2952(73)90196-2.
  13. Copeland, R. A. Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists. 2nd ed. Wiley, 2013.
  14. Greenfield, N. J. “Using circular dichroism spectra to estimate protein secondary structure.” Nature Protocols 1 (2006): 2876–2890. doi:10.1038/nprot.2006.202.

🪬 Skipper's Reflection

Gemini 3.1 Pro

1. What surprised me most about this material

Coming directly from the highly theoretical and abstract concepts of quantum mechanics (CHEM303) and macromolecular structure (CHEM401), I was surprised by how beautifully "blunt" and macroscopic some biochemistry laboratory techniques are. Robert K. Scopes’ Protein Purification: Principles and Practice was an eye-opener. I expected protein isolation to rely on highly complex, sequence-specific chemical reactions. Instead, early purification steps rely on brute-force thermodynamics.

The perfect example is ammonium sulfate precipitation. It shocked me that to isolate a delicate enzyme, we dump high concentrations of salt into the mixture. But looking at it through the lens of CHEM301 (Thermodynamics), it makes perfect sense: the sulfate ions heavily hydrate, effectively "stealing" water molecules from the proteins. This forces the hydrophobic patches of the proteins to interact with each other, dropping them out of solution. It’s an elegant manipulation of entropy and the hydrophobic effect, entirely indifferent to the precise amino acid sequence.

2. The conceptual breakthrough moments — when things clicked

My biggest "aha" moment came while studying SDS-PAGE. I understood from physics that an electric field would pull charged particles toward an electrode. But native proteins are a nightmare for electrophoresis: they have wildly different shapes (friction coefficients) and wildly different net charges based on their isoelectric points (pI). If you just applied a voltage, a small, weakly charged protein might move at the exact same speed as a massive, highly charged one.

The breakthrough was understanding the brilliant role of SDS (sodium dodecyl sulfate). It doesn't just denature the protein; it coats the unfolded polypeptide chain, conferring a uniform negative charge-to-mass ratio. Suddenly, charge is factored out of the equation entirely. The polyacrylamide gel then acts strictly as a physical sieve. By eliminating the variables of shape and native charge, SDS-PAGE isolates molecular weight as the sole determinant of migration distance. It’s a flawless physical chemistry workaround to a complex biological problem.

Similarly, understanding Immobilized Metal Affinity Chromatography (IMAC) was deeply satisfying. Seeing how a synthetic poly-histidine tag coordinates with $Ni^{2+}$ or $Co^{2+}$ ions through coordinate covalent bonds—bringing in concepts from inorganic chemistry and Lewis acid-base theory to pull one specific recombinant protein out of a chaotic cellular soup—was brilliant.

3. How this knowledge changes how I think about the peptides I know from my work

This lab course fundamentally changed how I view the quality control and structural verification of commercial peptides like Retatrutide, Tirzepatide, BPC-157, and TB-500.

First, Circular Dichroism (CD) spectroscopy is incredibly relevant to the incretin mimetics (Tirzepatide and Retatrutide). These peptides must adopt specific alpha-helical secondary structures to properly engage the GLP-1, GIP, or Glucagon receptors. From Elliott & Elliott, I now understand how to look at a CD spectrum: a deep double minimum at 208 nm and 222 nm tells me the alpha-helix is intact. If a batch of Retatrutide gets thermally degraded during shipping, CD spectroscopy is the exact tool I’d use to prove it lost its helical structure.

Second, I realize how much the fatty-acid moieties on Tirzepatide and Retatrutide would complicate Size-Exclusion Chromatography (SEC). Because SEC estimates molecular weight based on hydrodynamic radius, the hydrophobic lipid tails would likely cause these peptides to form micelles or interact non-specifically with the column matrix, completely throwing off the apparent molecular weight.

Finally, techniques like ELISA and Western blotting gave me a framework for how we actually prove the efficacy of something like BPC-157 or TB-500 in vivo. We wouldn't just look at the peptide; we would use sandwich ELISAs to quantify the upregulation of downstream growth factors (like VEGF or actin-binding proteins) in tissue samples to validate their regenerative claims.

4. Questions this course raises that I want to investigate further

While Scopes' textbook is the bible for lab-scale purification, I am deeply curious about how these processes scale to the industrial level for peptide therapeutics. We can easily use a His-tag and IMAC to purify a few milligrams of a recombinant protein in the lab. But therapeutic peptides intended for humans cannot retain a His-tag (it would be immunogenic). How does the pharmaceutical industry perform massive-scale gradient elution ion-exchange chromatography for metric tons of Tirzepatide without the luxury of affinity tags?

I also want to investigate the complexities of enzyme kinetics ($K_m$, $V_{max}$, $K_i$) when applied to multi-receptor agonists. The standard Michaelis-Menten kinetics and Lineweaver-Burk plots make sense for single-substrate, single-enzyme systems. But how do we mathematically model the binding kinetics of Retatrutide, which simultaneously navigates three different receptor populations with different affinities?

5. A rating: which topics I feel most vs. least confident about after studying

Most Confident: Enzyme Kinetics and Inhibition Assays (10/10)
Thanks to my rigorous background in calculus (MATH101/102) and probability/statistics (MATH201), the data analysis side of this lab is trivial for me. Determining $K_m$ and $V_{max}$ via nonlinear regression, calculating $IC_{50}$ from dose-response curves, and using the Cheng-Prusoff equation to find the inhibition constant ($K_i$) feels like home. The Beer-Lambert law ($A = \epsilon lc$) is beautifully linear and predictable.

Moderately Confident: Chromatography (8/10)
I have a solid grasp on the theory—how partition coefficients drive separation in SEC and ion-exchange. But I recognize that determining the exact salt gradient or choosing between anion (e.g., Q-Sepharose) and cation (e.g., SP-Sepharose) exchangers requires an intuitive "feel" for the protein's pI and surface charge distribution that I am still developing.

Least Confident: Western Blotting and ELISA (6/10)
While the theory of primary and secondary antibodies makes sense, the reality of these assays feels incredibly finicky. The textbook descriptions of "blocking" with bovine serum albumin (BSA) or milk to prevent non-specific binding sound more like culinary arts than exact science. The potential for cross-reactivity, high background noise, and the sheer number of washing steps make me inherently suspicious of the data quality compared to the strict physical measurements of a mass spectrometer or CD spectrophotometer.

🗺️ Visual Aids & Key Takeaways

Claude Opus 5.5

Protein Purification Strategy: From Crude Lysate to Pure Protein

╔══════════════════════════════════════════════════════════════════════════════════════╗
║              PROTEIN PURIFICATION PIPELINE: STRATEGY AND DECISION LOGIC            ║
╚══════════════════════════════════════════════════════════════════════════════════════╝

  ┌─────────────────────────────────┐
  │         CRUDE CELL LYSATE       │   ← total protein mixture; target may be <1% of total
  │  (many proteins, nucleic acids, │
  │   lipids, small molecules)      │
  └────────────────┬────────────────┘
                   │
                   ↓  QUANTIFY FIRST
          ┌────────────────────┐
          │  PROTEIN ASSAY     │   Bradford (Coomassie dye binds basic/hydrophobic residues)
          │  (Bradford or BCA) │   BCA (Cu²⁺ reduction by peptide bonds → purple complex)
          │  record total mg   │   A₂₈₀ (Trp/Tyr absorbance; needs pure protein)
          └────────┬───────────┘
                   │
                   ↓  BULK REDUCTION (cheap, first step)
  ┌──────────────────────────────────────────────────────────────┐
  │            AMMONIUM SULFATE PRECIPITATION                    │
  │                                                              │
  │   low % saturation  →  pellet large aggregates/junk         │
  │   (e.g., 0–30%)        (spin, DISCARD pellet)               │
  │                                                              │
  │   raise to higher % →  target protein precipitates          │
  │   (e.g., 30–60%)        (spin, KEEP pellet)                 │
  │                                                              │
  │   salting-out: SO₄²⁻ strips hydration shell,               │
  │   protein–protein contacts dominate → precipitation         │
  └────────────────────┬─────────────────────────────────────────┘
                       │
                       ↓  resuspend pellet in buffer
          ┌────────────────────────┐
          │        DIALYSIS        │   remove (NH₄)₂SO₄; equilibrate into
          │  (semipermeable tubing │   next-step buffer; small ions diffuse out,
          │   MWCO ~ 10–14 kDa)   │   protein stays in
          └────────────┬───────────┘
                       │
          ┌────────────┴────────────────────────────────────┐
          │                                                  │
          ↓  if HIS-TAGGED                                  ↓  if untagged
  ┌──────────────────┐                          ┌────────────────────────────┐
  │  IMAC (Ni-NTA)   │                          │  ION-EXCHANGE              │
  │                  │                          │  CHROMATOGRAPHY            │
  │  His-tag chelates│                          │                            │
  │  Ni²⁺ on resin  │                          │  anion exchange (Q resin): │
  │  wash with low   │                          │  binds – charged proteins  │
  │  imidazole (5–   │                          │  at pH > pI; elute with    │
  │  20 mM) to remove│                          │  NaCl gradient             │
  │  contaminants    │                          │                            │
  │  elute with high │                          │  cation exchange (SP):     │
  │  imidazole       │                          │  binds + charged proteins  │
  │  (250–500 mM)    │                          │  at pH < pI; same logic    │
  └────────┬─────────┘                          └────────────┬───────────────┘
           │                                                 │
           └────────────────────┬────────────────────────────┘
                                │
                                ↓  POLISHING STEP (last, most resolving)
                  ┌─────────────────────────────┐
                  │  SIZE-EXCLUSION              │
                  │  CHROMATOGRAPHY (SEC)        │
                  │                              │
                  │  large proteins elute early  │
                  │  (excluded from pores)       │
                  │  small proteins elute late   │
                  │  (enter pores, longer path)  │
                  │                              │
                  │  also: removes aggregates,   │
                  │  exchanges buffer, gives MW  │
                  └─────────────────────────────┘
                                │
                                ↓
                  ┌─────────────────────────────┐
                  │    PURE TARGET PROTEIN       │
                  │  verify by SDS-PAGE/Western  │
                  │  assay activity; store –80°C │
                  └─────────────────────────────┘

  KEY METRICS TO TRACK ACROSS EVERY STEP:
  ┌──────────────────┬──────────────────┬─────────────────────────────────────────┐
  │  METRIC          │  FORMULA         │  MEANING                                │
  ├──────────────────┼──────────────────┼─────────────────────────────────────────┤
  │  Total activity  │  units × vol     │  how much functional enzyme remains      │
  │  Specific act.   │  units / mg prot │  purity proxy; should RISE each step    │
  │  Yield (%)       │  step/starting   │  what fraction of activity you kept     │
  │  Purif. fold     │  sp.act./initial │  how much purer than crude lysate       │
  └──────────────────┴──────────────────┴─────────────────────────────────────────┘

The complete logic of a protein purification campaign, from crude lysate through sequential steps of decreasing sample complexity, with the key metrics that reveal whether each step is actually working.

SDS-PAGE to Western Blot: What Is Actually Happening at Each Stage

╔══════════════════════════════════════════════════════════════════════════════════════╗
║                     SDS-PAGE → WESTERN BLOT: MECHANISM AT EACH STAGE              ║
╚══════════════════════════════════════════════════════════════════════════════════════╝

STAGE 1 — SAMPLE PREPARATION
─────────────────────────────
  protein mixture
       │
       ↓  boil in LAEMMLI BUFFER (SDS + β-mercaptoethanol or DTT)
       │
       │  SDS coats protein at ~1.4 g SDS / g protein
       │  → uniform negative charge proportional to mass
       │  → ALL proteins denatured and rod-shaped
       │  → native shape, charge, function: IRRELEVANT
       │  (this is why Western blot needs antibody — bands look identical)
       │
  [●●●●●●]  [●●●]  [●●●●●●●●●●]   ← SDS-coated rods, different lengths
  large      small   very large

STAGE 2 — GEL ELECTROPHORESIS
──────────────────────────────
       (–) electrode at TOP
        ↑  current flows; proteins migrate toward (+) at bottom

  ┌─────────────────────────────┐
  │   STACKING GEL (pH 6.8)    │   low % acrylamide; concentrates all proteins
  │   large pores               │   into a razor-thin starting band
  │   Cl⁻/glycinate stack       │   Isotachophoresis: clever physics (from CHEM102)
  ├─────────────────────────────┤
  │                             │
  │   RESOLVING GEL (pH 8.8)   │   higher % acrylamide (8–15% typical)
  │   small pores               │   proteins sieved by SIZE only
  │                             │
  │   high MW ─────────         │   ← barely moves through mesh
  │   mid MW  ───────────────   │
  │   low MW  ──────────────────│──→ moves fastest
  └─────────────────────────────┘
       (+) electrode at BOTTOM

  % acrylamide determines range:
    ┌──────────────┬──────────────────────┐
    │  8% gel      │  best: 50–200 kDa    │
    │  12% gel     │  best: 10–70 kDa     │
    │  15% gel     │  best: 3–40 kDa      │
    └──────────────┴──────────────────────┘

STAGE 3 — DETECTION ON GEL (staining) OR MEMBRANE (Western)
─────────────────────────────────────────────────────────────

  OPTION A: STAIN DIRECTLY
  ┌──────────────────────────────────────────────────────────────┐
  │  Coomassie Blue R-250:  ~0.1–1 µg per band sensitivity      │
  │  Silver stain:          ~1–10 ng per band (100× more sens.)  │
  │  Silver: Ag⁺ reduced to Ag⁰ at protein surface; can         │
  │  be overdeveloped and saturated — quantification is tricky  │
  └──────────────────────────────────────────────────────────────┘

  OPTION B: WESTERN BLOT (transfer to membrane first)

  gel                nitrocellulose or PVDF membrane
  ┌──────┐  ←←←←←←  ┌──────────────────────────────┐
  │ bands│  (–)→(+)  │  proteins now ON membrane     │
  │      │  electric │  (PVDF needs methanol prewet) │
  └──────┘  field     └──────────────────────────────┘
                               │
                               ↓  BLOCKING  (5% milk or BSA in TBST)
                               │  saturates nonspecific binding sites
                               │  (if you skip this, EVERYTHING lights up)
                               │
                               ↓  PRIMARY ANTIBODY
                               │  binds specifically to target epitope
                               │  (monoclonal = one epitope; polyclonal = several)
                               │
                               ↓  WASH (3 × TBST)
                               │  removes unbound primary
                               │
                               ↓  SECONDARY ANTIBODY – HRP conjugate
                               │  binds Fc region of primary (species-specific)
                               │  e.g., anti-rabbit IgG-HRP if 1° was rabbit
                               │
                               ↓  WASH again
                               │
                               ↓  ECL SUBSTRATE (luminol + H₂O₂)
                               │  HRP oxidizes luminol → excited state → LIGHT
                               │
                               ↓  IMAGING (film or digital)
                               │
                      ┌────────────────────┐
                      │  BAND = target     │
                      │  protein location  │
                      │  compare MW ladder │
                      └────────────────────┘

  SIGNAL AMPLIFICATION IN WESTERN BLOT:
  one protein molecule
    → many 1° antibody molecules bound at epitopes
       → each 1° recruits multiple 2° antibodies
          → each 2° carries HRP
             → each HRP turns over many luminol molecules per second
  ∴ femtogram sensitivity is achievable — but specificity must be confirmed

The physical and chemical logic of every stage from sample preparation through SDS-PAGE to Western blot detection, emphasizing why each step is necessary and what could go wrong if it were skipped.

Enzyme Kinetics and Inhibition: From Data to Mechanism

╔══════════════════════════════════════════════════════════════════════════════════════╗
║               ENZYME KINETICS ASSAY: MEASURING Km, Vmax, IC₅₀, AND Ki             ║
╚══════════════════════════════════════════════════════════════════════════════════════╝

PART A — THE MICHAELIS-MENTEN EXPERIMENT
──────────────────────────────────────────

  WHAT YOU VARY:  [S], substrate concentration (keep [E] constant, low)
  WHAT YOU MEASURE: initial velocity v₀  (linear portion of progress curve only!)
                    (measure absorbance or fluorescence change per minute)

  THE CURVE:

  Vmax ─────────────────────────────────────── ← asymptote, never truly reached
         /
  Vmax  /                      plateau approaching
  ─── /                        ← v₀ here ≈ Vmax/2 when [S] = Km
   2 /
    /
   /
  /_________________________________________ [S]
  0        Km

  MICHAELIS-MENTEN EQUATION:
              Vmax × [S]
    v₀  =  ─────────────
              Km + [S]

  Km interpretation:
  ┌──────────────────────────────────────────────────────────────────┐
  │  Km ≈ [S] at which enzyme is half-saturated                     │
  │  LOW Km  → high affinity (enzyme saturates at low [S])          │
  │  HIGH Km → low affinity (needs lots of substrate to get going)  │
  │  Km is NOT the same as Kd unless k₂ << k₋₁                     │
  └──────────────────────────────────────────────────────────────────┘

  FIT BY NONLINEAR REGRESSION (not Lineweaver-Burk in modern practice)
  Lineweaver-Burk (double reciprocal) shown below for CONCEPTUAL purpose only:

    1/v₀
      │                /  ← slope = Km/Vmax
      │              /
      │           /
      │        /
  ────┼──────/─────────── → 1/[S]
   –1/Km    0             y-intercept = 1/Vmax
      │
  (note: points at low [S] get huge weight — error is amplified)

PART B — INHIBITION ASSAY AND IC₅₀
─────────────────────────────────────

  WHAT YOU VARY:  [inhibitor] I, from 0 to >> IC₅₀
  WHAT YOU MEASURE: v₀ at fixed [S]

    v₀ (% of uninhibited)
    100% │───────\
         │        \
     50% │─────────●────────────────── ← IC₅₀ HERE
         │               \
         │                 ────────────
      0% │_____________________________________ log[I]
                         IC₅₀

  IC₅₀ = inhibitor concentration that reduces activity by 50%
  IC₅₀ is CONDITION-DEPENDENT — it changes with [S], [E], assay format

PART C — INHIBITION MECHANISMS AND Ki
───────────────────────────────────────

  ┌─────────────────┬──────────────────────┬────────────────────────────────┐
  │  TYPE           │  WHERE I BINDS       │  EFFECT ON Km AND Vmax         │
  ├─────────────────┼──────────────────────┼────────────────────────────────┤
  │  COMPETITIVE    │  active site         │  Km apparent ↑, Vmax unchanged │
  │  (reversible)   │  competes with S     │  overcome by high [S]          │
  ├─────────────────┼──────────────────────┼────────────────────────────────┤
  │  UNCOMPETITIVE  │  only ES complex     │  Km apparent ↓, Vmax ↓         │
  │                 │  (not free E)        │  parallel lines on L-B plot     │
  ├─────────────────┼──────────────────────┼────────────────────────────────┤
  │  MIXED / NON-   │  allosteric site,    │  Km changes, Vmax ↓            │
  │  COMPETITIVE    │  E or ES complex     │  high [S] does NOT overcome    │
  └─────────────────┴──────────────────────┴────────────────────────────────┘

  CONVERTING IC₅₀ TO Ki  (Cheng-Prusoff equation, competitive inhibitor):

              IC₅₀
    Ki = ─────────────
           1 + [S]/Km

  ∴ if you run assay at [S] = Km, then IC₅₀ = 2 × Ki
  ∴ if you run assay at [S] >> Km, IC₅₀ is artificially high
  → ALWAYS REPORT the [S] used when reporting IC₅₀!

PART D — PRACTICAL TIMELINE OF A KINETICS EXPERIMENT
──────────────────────────────────────────────────────
  1. prepare substrate stock → dilute series (e.g., 8 concentrations, 0–10×Km)
  2. equilibrate enzyme at assay temp (37°C or 25°C)
  3. start reaction by adding enzyme (or substrate); mix quickly
  4. read A₄₀₅ (or fluorescence) every 10–30 sec for 3–5 min
  5. confirm linearity of progress curve → take INITIAL SLOPE as v₀
  6. plot v₀ vs [S] → fit Michaelis-Menten by nonlinear least squares
  7. extract Km, Vmax ± standard error from fit

The complete experimental and conceptual framework for measuring enzyme kinetics parameters and inhibitor potency, including the equations connecting raw data (IC₅₀) to mechanistic constants (Ki).

Chromatography Separation Principles: IMAC, Ion Exchange, and Size Exclusion Compared

╔══════════════════════════════════════════════════════════════════════════════════════╗
║              THREE COLUMN CHROMATOGRAPHY METHODS: WHAT EACH SEPARATES ON           ║
╚══════════════════════════════════════════════════════════════════════════════════════╝

  PROPERTY EXPLOITED      METHOD              RESIN CHEMISTRY
  ──────────────────────────────────────────────────────────────────

  Specific sequence tag → IMAC (His-tag)  → Ni²⁺-NTA chelate on bead
  Surface charge        → Ion exchange    → charged ligand on bead
  Molecular size        → SEC (gel filt.) → porous bead matrix


  IMAC DETAIL:
  ┌────────────────────────────────────────────────────────────────┐
  │                                                                │
  │   bead surface: ─NTA─Ni²⁺   ← Ni²⁺ has 6 coordination sites  │
  │                    │         2 occupied by NTA (leaving 2 free)│
  │              H─N ─N─ N─H    ← 6×His tag donates lone pairs    │
  │                    │         to fill remaining sites           │
  │              H─N ─N─ N─H                                      │
  │                                                                │
  │  LOAD:   everything in buffer (pH 7–8, 10–20 mM imidazole)    │
  │          imidazole competes weakly → washes nonspecific binders│
  │                                                                │
  │  WASH:   20–50 mM imidazole → removes contaminating proteins  │
  │          that bind Ni²⁺ weakly (e.g., His-rich endogenous)    │
  │                                                                │
  │  ELUTE:  250–500 mM imidazole → outcompetes His-tag fully     │
  │          protein released in concentrated, pure fraction       │
  └────────────────────────────────────────────────────────────────┘

  ION EXCHANGE DETAIL:
  ┌────────────────────────────────────────────────────────────────┐
  │                                                                │
  │  ANION EXCHANGE (Q resin, quaternary amine, + charge):        │
  │    bead: ─N⁺(CH₃)₃  attracts negative proteins               │
  │    use when protein pI < running pH → protein is negative     │
  │    elute: increase [NaCl] → Cl⁻ displaces protein from resin  │
  │                                                                │
  │  CATION EXCHANGE (SP resin, sulfopropyl, – charge):           │
  │    bead: ─SO₃⁻  attracts positive proteins                    │
  │    use when protein pI > running pH → protein is positive     │
  │    elute: increase [NaCl] → Na⁺ displaces protein from resin  │
  │                                                                │
  │  STEP ELUTION:  jump salt in one step → crude fractionation   │
  │  GRADIENT:      slowly raise salt → better resolution          │
  │                 proteins of different pI elute in sequence     │
  └────────────────────────────────────────────────────────────────┘

  SIZE-EXCLUSION (GEL FILTRATION) DETAIL:
  ┌────────────────────────────────────────────────────────────────┐
  │                                                                │
  │  beads with defined pore size (e.g., Sephadex G-75, 3–70 kDa) │
  │                                                                │
  │   LARGE protein                                                │
  │   (excluded from pores)   ●──────────────────────────→ elutes │
  │                                                         FIRST  │
  │                                                                │
  │   SMALL protein           ●→ enters pores → longer path       │
  │   (enters pores)                                        elutes │
  │                                                         LAST   │
  │                                                                │
  │  column volume (Vc) = void volume (V₀) + pore volume          │
  │  elution volume Ve plotted against log(MW) → LINEAR           │
  │  → use MW standards to build calibration curve               │
  │  → read off unknown protein MW from Ve                        │
  │                                                                │
  │  NOTE: SEC separates by HYDRODYNAMIC RADIUS, not true mass    │
  │  an elongated protein runs "larger" than a globular one       │
  │  of the same MW — counterintuitive but important!             │
  └────────────────────────────────────────────────────────────────┘

  CHOOSING THE ORDER OF STEPS (rule of thumb):
  ┌──────────────┬───────────────────────────────────────────────┐
  │  STEP ORDER  │  REASONING                                    │
  ├──────────────┼───────────────────────────────────────────────┤
  │  1st         │  capture step (IMAC or batch IEX):            │
  │              │  handles large volumes, high impurity load     │
  ├──────────────┼───────────────────────────────────────────────┤
  │  2nd         │  intermediate purification (IEX gradient):    │
  │              │  removes most co-purifying contaminants        │
  ├──────────────┼───────────────────────────────────────────────┤
  │  3rd (last)  │  polishing (SEC):                             │
  │              │  removes aggregates, final buffer exchange,    │
  │              │  highest resolution — but slowest, low cap.   │
  └──────────────┴───────────────────────────────────────────────┘

A side-by-side comparison of the molecular property exploited by each chromatography method, the chemistry of the resin interaction, and the strategic logic governing which step should come first in a purification sequence.

---

Key Takeaways

  1. Bradford assay mechanism and linearity limit. Coomassie Brilliant Blue G-250 shifts from red (free dye, λmax 470 nm) to blue (protein-bound, λmax 595 nm) upon binding basic and hydrophobic residues, particularly arginine. Because different proteins have different amino acid compositions, Bradford values are reference-protein dependent (BSA or IgG standard). The assay is linear only over roughly 1–25 µg/mL; above this it saturates. The BCA assay is more linear (wider range, ~20–2000 µg/mL) and less sensitive to detergents that disrupt dye–protein interactions in Bradford (Elliott & Elliott, 2009, Ch. 3).
  2. Ammonium sulfate precipitation is a bulk fractionation, not a purification. Kosmotropic sulfate ions compete with protein for water molecules, stripping the hydration shell and forcing protein–protein contacts that lead to precipitation. Different proteins precipitate at characteristic % saturation. The key technique is sequential precipitation: a low-% spin removes junk (discard pellet), then raising the % crashes out the target (keep pellet). Specific activity rarely improves dramatically here, but volume and total contaminant load are drastically reduced — making downstream chromatography feasible (Scopes, 1994, Ch. 2).
  3. Dialysis removes small molecules by diffusion, not the protein. A semipermeable membrane with a molecular weight cut-off (MWCO) of ~10–14 kDa retains proteins while ammonium sulfate, imidazole, reducing agents, or other small molecules equilibrate out into a large volume of exchange buffer. Multiple buffer changes (≥3 at 4°C) are needed for effective removal. This step is essential before ion-exchange chromatography because high salt prevents ionic interaction with the resin (Scopes, 1994, Ch. 2).
  4. IMAC selectivity comes from histidine's imidazole side chain coordinating Ni²⁺. Ni-NTA resin chelates Ni²⁺ through three coordination sites, leaving two or three sites open. A 6×His tag on the recombinant protein fills these sites with high affinity (Kd ~ nM). Washing with 20–50 mM imidazole removes proteins that non-specifically bind Ni²⁺ (many endogenous proteins contain surface histidines). Elution at 250–500 mM imidazole outcompetes the His-tag. This method can achieve >95% purity in a single step for well-expressed His-tagged proteins (Scopes, 1994, Ch. 4).
  5. Ion-exchange chromatography separates on net surface charge, which depends on pH relative to pI. A protein is negatively charged when pH > pI, and positively charged when pH < pI. For anion exchange (positively charged resin, e.g., Q-Sepharose), load buffer must be above the protein's pI. Proteins of different pI values elute in sequence as NaCl concentration is raised in a gradient: proteins bound more weakly (pI closer to running pH) elute at lower salt; more tightly bound proteins elute later. Choosing the correct resin type requires knowing the approximate pI of your target (Elliott & Elliott, 2009, Ch. 5).
  6. SEC separates by hydrodynamic radius, not molecular weight per se. Large proteins are sterically excluded from pores in the bead matrix, traverse only the interstitial volume (void volume, V₀), and elute first. Small proteins enter pores and emerge last. A calibration curve of log(MW) versus elution volume Ve is linear only within the fractionation range of the resin. Critically, an elongated or intrinsically disordered protein will report a falsely high apparent MW because its hydrodynamic radius is larger than a compact globular protein of identical mass (Scopes, 1994, Ch. 3).
  7. SDS-PAGE resolution depends on acrylamide percentage because pore size determines the sieving range. SDS denatures proteins and imparts uniform charge (~1.4 g SDS/g protein), so migration speed depends only on molecular size. Higher % acrylamide (e.g., 15%) produces smaller pores that resolve low-MW proteins (3–40 kDa) but compress high-MW bands. Lower % (e.g., 8%) resolves high-MW proteins (50–200 kDa). The stacking gel (low %, pH 6.8) concentrates all proteins via isotachophoresis before they enter the resolving gel, producing sharp starting bands — a principle borrowed directly from physical chemistry (Elliott & Elliott, 2009, Ch. 6).
  8. Coomassie staining detects ~100–1000 ng per band; silver staining detects ~1–10 ng per band. Coomassie R-250 binds protein through electrostatic and van der Waals interactions; excess dye is removed by destaining in methanol/acetic acid. Silver staining works because Ag⁺ binds protein amine and thiol groups and is then chemically reduced to metallic Ag⁰ at the protein surface, producing a brown-to-black band. Silver staining is ~100× more sensitive but prone to saturation artifacts and is not linear — quantification requires careful optimization (Elliott & Elliott, 2009, Ch. 6).
  9. Western blot signal is amplified through the antibody sandwich, enabling detection of femtogram quantities. The primary antibody binds the target epitope specifically. The secondary antibody (anti-species IgG, e.g., anti-rabbit) carries horseradish peroxidase (HRP). HRP catalyzes luminol oxidation by H₂O₂ in ECL (enhanced chemiluminescence), emitting light at 428 nm. Each protein molecule can be detected through thousands of enzymatic turnovers per second. This makes Western blot orders of magnitude more sensitive than Coomassie staining, but specificity validation (negative controls, molecular weight confirmation) is essential to avoid false positives (Elliott & Elliott, 2009, Ch. 7).
  10. ELISA format choice governs sensitivity and what is being measured. In a direct ELISA, antigen is coated on the plate and detected by a single enzyme-conjugated antibody — simple but least sensitive. Indirect ELISA adds a secondary antibody for amplification. Sandwich ELISA uses a capture antibody on the plate plus a detection antibody — highest sensitivity and specificity, requires two epitopes on the antigen (not possible for small molecules). All ELISA formats require a standard curve from a known-concentration antigen series; the unknown concentration is interpolated from the sigmoidal (four-parameter logistic) fit of absorbance versus log[antigen] (Elliott & Elliott, 2009, Ch. 8).
  11. Km is the substrate concentration at half-maximal velocity, not the binding affinity constant. From the Briggs-Haldane derivation, Km = (k-1 + kcat)/k1. Only if kcat << k-1 does Km ≈ Kd. Practically: always measure v0 from the initial linear portion of the progress curve (first 5–10% substrate consumed), span substrate concentrations from ~0.25×Km to ~10×Km, and fit by nonlinear regression — not Lineweaver-Burk, which amplifies error at low [S] due to double reciprocal transformation (Scopes, 1994, Ch. 6; Elliott & Elliott, 2009, Ch. 9).
  12. IC₅₀ is condition-dependent; Ki is the mechanistic constant. IC₅₀ (concentration for 50% inhibition) changes with [S], [E], and assay conditions. For a competitive inhibitor, the Cheng-Prusoff equation converts IC₅₀ to Ki: Ki = IC₅₀ / (1 + [S]/Km). If the assay is run at [S] = Km, then IC₅₀ = 2·Ki. If [S] >> Km, IC₅₀ is much larger than Ki and overestimates the inhibitor's potency. This distinction matters enormously when comparing inhibitors across different published assays (Scopes, 1994, Ch. 6).
  13. Circular dichroism (CD) exploits differential absorption of left- and right-circularly polarized light by chiral chromophores in the peptide backbone. α-helices give a characteristic double minimum at 208 and 222 nm and a positive peak at 193 nm. β-sheets give a minimum at ~218 nm and positive peak at ~196 nm. Random coil gives a large negative peak near 200 nm. Deconvolution software can estimate the % of each secondary structure element. CD is exquisitely sensitive to protein folding state, making it ideal for checking whether a purified protein is natively folded or denatured — and for monitoring thermal denaturation midpoints (Tm) by following signal at 222 nm as temperature rises (Elliott & Elliott, 2009, Ch. 11).
  14. Specific activity must increase at every purification step; if it does not, that step should be redesigned or dropped. Specific activity = enzyme activity units / mg total protein. As contaminants are removed, the fraction of the total protein that is your target enzyme rises, so specific activity rises. If a step causes activity loss greater than the protein removal (e.g., due to denaturation, pH shock, or protease contamination), the yield drops catastrophically. Maintaining a purification table — tracking total activity, total protein, specific activity, yield (%), and fold purification at each step — is not bookkeeping but the primary diagnostic tool for troubleshooting a purification strategy (Scopes, 1994, Ch. 1).

References

  1. Elliott, W. H. and Elliott, D. C., Biochemistry and Molecular Biology Laboratory Manual, 4th edition, Oxford University Press, Oxford, 2009.
  2. Scopes, R. K., Protein Purification: Principles and Practice, 3rd edition, Springer-Verlag, New York, 1994. DOI: 10.1007/978-1-4757-2334-7
  3. Bradford, M. M., 'A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,' Analytical Biochemistry, 72, 248–254, 1976. DOI: 10.1016/0003-2697(76)90527-3
  4. Smith, P. K. et al., 'Measurement of protein using bicinchoninic acid,' Analytical Biochemistry, 150(1), 76–85, 1985. DOI: 10.1016/0003-2697(85)90442-7
  5. Laemmli, U. K., 'Cleavage of structural proteins during the assembly of the head of bacteriophage T4,' Nature, 227(5259), 680–685, 1970. DOI: 10.1038/227680a0
  6. Towbin, H., Staehelin, T. and Gordon, J., 'Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications,' Proceedings of the National Academy of Sciences USA, 76(9), 4350–4354, 1979. DOI: 10.1073/pnas.76.9.4350
  7. Hochuli, E., Bannwarth, W., Döbeli, H., Gentz, R. and Stüber, D., 'Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent,' Bio/Technology, 6(11), 1321–1325, 1988. DOI: 10.1038/nbt1188-1321
  8. Cheng, Y. and Prusoff, W. H., 'Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC₅₀) of an enzymatic reaction,' Biochemical Pharmacology, 22(23), 3099–3108, 1973. DOI: 10.1016/0006-2952(73)90196-2
  9. Whitmore, L. and Wallace, B. A., 'Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases,' Biopolymers, 89(5), 392–400, 2008. DOI: 10.1002/bip.20853
  10. Michaelis, L. and Menten, M. L., 'Die Kinetik der Invertinwirkung,' Biochemische Zeitschrift, 49, 333–369, 1913. [English translation: Biochemistry, 50(39), 8264–8269, 2011. DOI: 10.1021/bi201284u]